Advertisement

Molecular Mechanisms of Chemical Carcinogenesis

  • P. N. Magee
  • A. E. Pegg
  • P. F. Swann
Part of the Handbuch der allgemeinen Pathologie book series (PATHOLOGIE, volume 6 / 6)

Abstract

The number of chemical compounds known to cause cancer in experimental animals is large and constantly increasing. Far fewer compounds are known with reasonable certainty to be carcinogenic in man. Nevertheless the view is widely held that a high proportion of human tumours are caused by environmental chemicals. It follows, therefore, that the incidence of cancer in man could be greatly reduced by the removal of as many chemical carcinogens as possible from the environment. Unfortunately this is a formidable task and it is very unlikely that all carcinogens will be completely eliminated in the foreseeable future. For this reason, as well as for its inherent scientific interest, it is desirable to understand the mechanism of action of chemical carcinogens so that ways may be devised of preventing or reducing their carcinogenic effects on the body.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abell, C.W., Falk, H.L., Shimkin, M.B., Weisburger, E.K., Weisburger, J.H., Gubareff, N.: Uracil mustard: a potent inducer of lung tumours in mice. Science 147, 1443–1444,(1965).PubMedCrossRefGoogle Scholar
  2. Abell, C.W., Heidelberger, C.: The interaction of carcinogenic hydrocarbons with tissues VIII. Binding of tritium labelled hydrocarbons to the soluble proteins of mouse skin. Cancer Res. 22, 931–946(1962).PubMedGoogle Scholar
  3. Adamson, R.H., Correa, P., Dalgard, D.W.: Occurrence of a primary liver carcinoma in a Rhesus monkey feed Aflatoxin Bt. J. nat. Cancer Inst. 50, 549–553 (1973).PubMedGoogle Scholar
  4. Akao, M., Kuroda, K., Wogan, G.N.: Aflatoxin BX: the kidney as a site of action in the mouse. Life Sci. 10, 495–501 (1971).CrossRefGoogle Scholar
  5. Alexander, P., Connell, D.I.: The failure of the potent mutagenic chemical, ethyl methanesul- phonate, to shorten the life-span of mice. In: Cellular basis and aetiology of late somatic effects of ionizing radiation, ed. by R.J.C. HARRIS, p. 259–265. London and New York: Academic Press 1963.Google Scholar
  6. Alfred, L.J., DI Paolo, J.A.: Reversible inhibition of DNA synthesis in hamster embryo cells in culture: action of 1,2-benzanthrcene and 7,12-dimethylbenz(a)anthracene. Cancer Res. 28, 60–65 (1968).PubMedGoogle Scholar
  7. Allcroft, R.: Aflatoxicosis in farm animals. In: L. A. GOLDBLATT (ed.), Aflatoxin: Scientific background, control and implications, p. 237–264. New York: Academic Press, Inc. 1969Google Scholar
  8. Ames, B.N., Durston, W.E., Yamasaki, E., Lee, F.D.: Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc. nat. Acad. Sci. (Wash.) 70, 2281–2285 (1973).CrossRefGoogle Scholar
  9. Ames, B.N., Sims, P., Grover, P.L.: Epoxides of polycyclic hydrocarbons are frameshift mutagens. Science 176, 47–49 (1972).PubMedCrossRefGoogle Scholar
  10. Arcos, J.C., Arcos, M.: Molecular geometry and mechanism of action of carcinogens. Progr. Drug. Res. 4, 407–581 (1962).Google Scholar
  11. Arcos, J.C., Argus, M.F.: Molecular geometry and carcinogenic activity of aromatic compounds. New perspectives. Advanc. Cancer Res. 11, 305–471 (1968).CrossRefGoogle Scholar
  12. Argus, M., Hoch-Ligeti, C.: Comparative study of the carcinogenic activity of nitrosamines. J. nat. Cancer Inst. 27, 695–709 (1961).PubMedGoogle Scholar
  13. Ayengar, P.K., Hayaishi, O., Nakajima, M., Tomida, I.: Enzymic aromatisation of 3,5-cyclohexa- diene-l,2-diol. Biochim. biophys. Acta (Amst.) 33, 111–119 (1959).CrossRefGoogle Scholar
  14. Ayres, J.L., Lee, D.J., Wales, H.H., Sinnhuber, R.O.: Aflatoxin structure and hepatocarcinogeni- city in rainbow trout (Salmo gairdneri). J. nat. Cancer Inst. 46, 561–564 (1971).PubMedGoogle Scholar
  15. Badger, G.M.: The carcinogenic hydrocarbons: chemical constitution and carcinogenic activity. Brit. J. Cancer 2, 309–350 (1948).PubMedCrossRefGoogle Scholar
  16. Badger, G.M.: Chemical constitution and carcinogenic activity. Adv. Cancer Res. 2, 73–127 (1954).PubMedCrossRefGoogle Scholar
  17. Badger, G.M., Cook, J.W., Hewett, C.L., Kennaway, E.L., Kennaway, N.M., Martin, R.H., Robinson, A. M.: The production of cancer by pure compounds V. Proc. roy. Soc. B 129, 439–467 (1940).CrossRefGoogle Scholar
  18. Badger, G.M., Elson, L.A., Haddow, A., Hewett, C.L., Robinson, A.M.: The inhibition of growth by chemical compounds. Proc. roy. Soc. B 130, 255–299 (1941).CrossRefGoogle Scholar
  19. Baird, W.M., Dipple, A., Grover, P.L., Sims, P., Brookes, P.: Studies on the formation of hydrocar- bon-deoxyribonucleoside products by the binding of derivatives of 7-methylbenz(a)anthracene to DNA in aqueous solution and in mouse embryo cells in culture. Cancer Res. 33, 2386–2392 (1973).PubMedGoogle Scholar
  20. Baldwin, R.W.: Immunological aspects of chemical carcinogenesis. Advanc. Cancer Res. 18, 1–75 (1973).CrossRefGoogle Scholar
  21. Barnes, J.M., Magee, P.N.: Some toxic properties of dimethylnitrosamine. Brit. J. industr. Med. 11, 167–174(1954).PubMedGoogle Scholar
  22. Barnes, J.M., Magee, P.N., Schoental, R.: Lesions in the lungs and livers of rats poisoned with the pyrrolizidine alkaloid fulvine and its N-oxide. J. Path. Bact. 88, 521–531 (1964).PubMedCrossRefGoogle Scholar
  23. Baron, R.L., Casterline, J.L., Orzel, R.: In vivo effects of carbamate insecticides on mammalian esterase enzymes. Toxicol, appl. Pharmacol. 9, 6–16 (1966).Google Scholar
  24. Bartsch, H., Hecker, E.: On the metabolic activation of the carcinogen-hydroxy-N-2-acetylamino-fluorene. III. Oxidation with horse-radish peroxidase to yield 2-nitrosofluorene and TV-acetoxy-A-acetylaminofluorene. Biochim. biophys. Acta (Amst.) 237, 567–578 (1971).CrossRefGoogle Scholar
  25. Bartsch, H., Miller, J. A., Miller, E.C.: Activwation of carcinogenic aromatic hydroxylamines by enzymatic O-acetylation. Proc. Amer. Ass. Cancer Res. 13, 12 (1972).Google Scholar
  26. Bartsch, H., Traut, M., Hecker, E.: On the metabolic activation of N-hydroxy-A-acetylamino- fluorene. II. Simultaneous formation of 2-nitrosofluorene and A-acetoxy-A-2-acetylaminofluorene from N-hydroxy-Af-2-acetylaminofluorene via a free radical intermediate. Biochim. biophys. Acta (Amst.) 237, 556–566 (1971).CrossRefGoogle Scholar
  27. Benda, P., Someda, K., Messer, J., Sweet, W.H.: Morphological and immunochemical studies of rat glial tumours and clonal strains propagated in culture. J. Neurosurg. 34, 310–323 (1971).PubMedCrossRefGoogle Scholar
  28. Berenbaum, M.C.: Effects of carcinogens on immune processes. Brit. med. Bull. 20, 159–164 (1964).PubMedGoogle Scholar
  29. Berenblum, I.: Two stage mechanism of carcinogenesis as an analytical tool. IN: Cellular control mechanisms and cancer, ed. by Emmelot, P. and Muhlbock, O., p. 259–267. Amsterdam: Elsevier 1964.Google Scholar
  30. Berenblum, I., Schoental, R.: The metabolism of 3,4 benzpyrene in mice and rats. I. The isolation of a hydroxy and a quinone derivative, and a consideration of their biological significance. Cancer Res. 3, 145–150 (1943).Google Scholar
  31. Berenblum, I., Schoental, R.: The metabolism of chrysene: the isolation of 3-methoxychrysene by methylation of the phenolic metabolite of chrysene from rat faeces. Biochem. J. 44, 604–606 (1949).Google Scholar
  32. Berenblum, L, Shubik, P.: The role of croton oil applications, associated with a single painting of a carcinogen, in tumour induction of the mouse’s skin. Brit. J. Cancer 1, 379–382 (1947a).PubMedCrossRefGoogle Scholar
  33. Berenblum, I., Shubik, P.: A new, quantitative, approach to the study of the stages of chemical carcinogenesis in the mouse’s skin. Brit. J. Cancer 1, 383–391 (1947b).PubMedCrossRefGoogle Scholar
  34. Bergquist, P.L., Mathews, R.E.F.: Occurrence and distribution of methylated purines in the ribonucleic acid of subcellular fractions. Biochem. J. 85, 305–313 (1962).PubMedGoogle Scholar
  35. Bhargava, P.M., Hadler, H. I., Heidelberger, C.: Studies on the structure of the skin protein-bound compounds following topical application of l,2,5,6-dibenzanthracene-9,10-C14. I. 2-phenyl- phenanthrene-3,2-dicarboxylic acid, a degradation product. J. Amer. chem. Soc. 77, 2877–2886 (1955).CrossRefGoogle Scholar
  36. Bhargava, P.M., Heidelberger, C.: Studies on the structure of the skin protein-bound compounds following topical application of l,2,5,6-dibenzanthracene-9,10-C14. II. Nature of the 2-phenyl- phenanthrene-3,2-dicarboxylic acid-protein bond. J. Amer. chem. Soc. 78, 3671–3677 (1956).CrossRefGoogle Scholar
  37. Black, D.N., Jago, M.V.: Interaction of dehydroheliotridine, a metabolite of heliotridine-based pyrrolizidine alkaloids with native and heat denatured deoxyribonucleic acid in vitro. Biochem. J. 118, 347–353 (1970).PubMedGoogle Scholar
  38. Blattman, L., Preussmann, R.: Struktur von Metaboliten carcinogener Dialkylnitrosamine im Rat-tenurin. Z. Krebsforsch. 79, 3–5 (1973).CrossRefGoogle Scholar
  39. Blyth, C.A., Freedman, R.B., Rabin, B.R.: Sex specific binding of steroid hormones to microsomal membranes of rat liver. Nature (Lond.) New Biol. 230, 137–139 (1971).Google Scholar
  40. Blyth, C.A., Freedman, R.B., Rabin, B.R.: The effects of aflatoxin on the sex-specific binding of steroid hormones to the microsomal membrane of rat liver. Europ. J. Biochem. 20,580–586 (1972).CrossRefGoogle Scholar
  41. Booth, J., Boyland, E., Sato, T., Sims, P.: Metabolism of polycyclic compounds 17. The reaction of 1:2-dihydronaphthalene and 1:2-epoxy-l :2:3:4:-tetrahydronaphthalene with glutathione catalysed by tissue preparations. Biochem. J. 77, 182–186 (1960).PubMedGoogle Scholar
  42. Borchert, P., Wislocki, P.G., Miller, J. A., Miller, E.C.: The metabolism of the naturally occurring hepatocarcinogen Safrole to l’-hydroxysafrole and the electrophilic reactivity of 1 ’-acetoxysafrole. Cancer Res. 33, 575–589 (1973).PubMedGoogle Scholar
  43. Borek, E.: The methylation of transfer RNA: Mechanism and function. Cold Spr. Harb. Symp. quant. Biol. 28, 139–148 (1963).Google Scholar
  44. Borek, E.: Introduction, Symposium: Transfer RNA and transfer RNA modification in differentiation and neoplasia. Cancer Res. 31, 596–597 (1971a).PubMedGoogle Scholar
  45. Borek, E. : Symposium: Transfer RNA and transfer RNA modification in differentiation and neoplasia. Cancer Res. 31, 591–721 (1971b).Google Scholar
  46. Borek, E., Srinivasan, P.R.: The methylation of nucleic acids. Annu. Rev. Biochem. 35, 275–298 (1966).CrossRefGoogle Scholar
  47. Boutwell, R.K.: Some biological aspects of skin carcinogenesis. Prog. exp. Tumour Res. 4, 207–250 (1964).Google Scholar
  48. Boveri, T.H.: Zur Frage der Entstehung maligner Tumoren. Jena: Fischer 1914.Google Scholar
  49. Bowden, G.T., Boutwell, R.K.: The binding of 7,12-dimethylbenz(a)anthracene (DMBA) to replicating and non-replicating DNA in vivo. Proc. Amer. Ass. Cancer Res. Abst. 109, 1973.Google Scholar
  50. Boyland, E.: The biological significance of metabolism of polycyclic compounds. Biochem. Soc. Symposia 5, 40–54(1950).Google Scholar
  51. Boyland, E.: Polycyclic hydrocarbons. Brit. med. Bull. 20, 121–126 (1964).Google Scholar
  52. Boyland, E.: The biochemistry of aromatic hydrocarbons, amines and urethane. In: Physico chemical mechanisms of carcinogenesis. The Jerusalem Symposia on Quantum Chemistry and Biochemistry, vol. 1, ed. by Bergmann, E.D. and Pullman, B., p. 25–44. Jerusalem: Israel Academy of Arts and Sciences 1969.Google Scholar
  53. Boyland, E.: Mercapturic acid conjugation. In: Handbuch der experimentellen Pharmakologie, vol. 28, pt. 2, ed. Brodie, B.B. and Gillette, J.R. Berlin-Heidelberg-New York: Springer 1971.Google Scholar
  54. Boyland, E., Green, B.: The interaction of polycyclic hydrocarbons and nucleic acids. Brit. J. Cancer 16, 507–517 (1962).PubMedCrossRefGoogle Scholar
  55. Boyland, E., Levi, A.A., Mawson, E.H., Roe, E.: Metabolism of polycyclic compounds. 4. Production of a dihydroxy-1:2:5:6-dibenzanthracene from a dibenzanthracene. Biochem. J. 35, 184–191 (1941).PubMedGoogle Scholar
  56. Boyland, E., Sims, P.: Metabolism of polycyclic compounds. 23. The metabolism of pyrene in rats and rabbits. Biochem. J. 90, 391–398 (1964a).PubMedGoogle Scholar
  57. Boyland, E., Sims, P.: Metabolism of polycyclic compounds. 24. The metabolism of benz(a)anthra- cene. Biochem. J. 91, 493–506 (1964b).PubMedGoogle Scholar
  58. Boyland, E., Sims, P.: Metabolism of polycyclic hydrocarbons. The metabolism of 7,12-dimethylbenz- (a)anthracene by rat liver homogenates. Biochem. J. 95, 780–787 (1965).PubMedGoogle Scholar
  59. Boyland, E., Sims, P.: Metabolism of polycyclic hydrocarbons. The metabolism of 9,10-epoxy-9,10- dihydrophenanthrene in rats. Biochem. J. 95, 788–792 (1965a).PubMedGoogle Scholar
  60. Boyland, E., Sims, P.: The metabolism of benz(a)anthracene and dibenz(a,h)anthracene and their 5,6-epoxy-5,6-dihydro derivatives by rat liver homogenates. Biochem. J. 97, 7–16 (1965b).PubMedGoogle Scholar
  61. Boyland, E., Sims, P.: The carcinogenic activities in mice of compounds related to benz(a)anthracene. Int. J. Cancer 2, 500–504 (1967).PubMedCrossRefGoogle Scholar
  62. Boyland, E., Sims, P., Huggins, C.: Induction of adrenal damage and cancer with metabolites of 7,12-dimethylbenz(a)anthracene. Nature (Lond.) 207, 816–817 (1965).CrossRefGoogle Scholar
  63. Boyland, E., Williams, K.: An enzyme catalysing the conjugation of epoxides with glutathione. Biochem. J. 94, 190–197 (1965).PubMedGoogle Scholar
  64. Brenner, S., Barnett, L., Crick, F.H.C., Orgel, A.: The theory of mutagenesis. J. molec. Biol. 3, 121–124(1961)CrossRefGoogle Scholar
  65. Brill, E., Radomsky, J.L.: Comparison of the in vitro and in vivo N-oxidation of the carcinogenic aromatic amines. Xenobiotica 1, 347–348 (1971).PubMedCrossRefGoogle Scholar
  66. Brookes, P.: Quantitative aspects of the reaction of some carcinogens with nucleic acids and the possible significance of such reactions in the process of carcinogenesis. Cancer Res. 26, 1994–2003 (1966).PubMedGoogle Scholar
  67. Brookes, P., Baird, W.M.: The role of the K region epoxide of 7-methylbenz(a)anthracene in the in vivo binding of the parent hydrocarbon. Proc. Amer. Ass. Cancer Res. Abstr.19 117 (1973).Google Scholar
  68. Brookes, P., Dipple, A.: On the mechanism of hydrocarbon carcinogenesis. In: Physico-chemical mechanisms of carcinogenesis, ed. Bergman, E.D. and Pullman, B. The Jerusalem symposia on Quantum Chemistry and Biochemistry, vol. 1, p. 139–148. Jerusalem: Israel Academy of Science and Humanities 1969.Google Scholar
  69. Brookes, P., Heidelberger, C.: Isolation and degradation of DNA from cells treated with tritium labelled 7,12-dimethylbenz(a)anthracene: studies on the nature of the binding of this carcinogen to DNA. Cancer Res. 29, 157–165 (1969).PubMedGoogle Scholar
  70. Brookes, P., Lawley, P.D.: Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic power of hydrocarbons and their binding to deoxyribonucleic acid. Nature (Lond.) 202, 781–784 (1964).CrossRefGoogle Scholar
  71. Brookes, P., Lawley, P.D.: Alkylating agents. Brit. med. Bull. 20, 91–95 (1964).PubMedGoogle Scholar
  72. Brooks, G.T., Harrison, A., Lewis, S.E.: Cyclodiene epoxide ring hydroxylation by microsomes from mammalian liver and houseflies. Biochem. Pharmacol 19, 255–273 (1970).PubMedCrossRefGoogle Scholar
  73. Brown, D.Q., Lubet, R. A., Kouri, R. E.: The relationship of aryl hydrocarbon hydroxylase (AHH) to benzo(a)pyrene (B.P.) induced cytotoxicity in cell cultures of hamster fetuses. Proc. Amer. Ass. Cancer Res. 12, 50 (1971).Google Scholar
  74. Brusick, D.J.: The mutagenic activity of /?-propiolactone in Saccharomyces cerevisiae. Mutation Res. 15, 425–434 (1972).PubMedCrossRefGoogle Scholar
  75. Bull, L.B., Culvenor, C.C. J., Dick, A.T.: The pyrrolizidine alkaloids. Their chemistry, pathogenicity and other biological properties. Amsterdam, Netherlands: North Holland 1968.Google Scholar
  76. Burnet, F.M.: Immunological factors in the process of carcinogenesis. Brit. med. Bull. 20, 154–158 (1964).PubMedGoogle Scholar
  77. Burnet, M.: Immunological aspects of malignant disease. Lancet 19671, 1171–1174.Google Scholar
  78. Butler, W.H.: Liver injury and aflatoxin, p. 175–186. IN: G.N. WOGAN (ed.), Mycotoxins in foodstuffs. Cambridge, Mass.: M.I.T. Press 1965.Google Scholar
  79. Butler, W.H.: Aflatoxicosis in Laboratory Animals. In: L. A. Goldblatt (ed.), Aflatoxin, scientific background, control, and implications, p. 223–236. New York: Academic Press, Inc. 1969.Google Scholar
  80. Butler, W. H., Greenblatt, M., Lijinsky, W.: Carcinogenesis by Aflatoxins Bl,G1, and B2. Cancer Res. 29, 2206–2211 (1969).PubMedGoogle Scholar
  81. Butler, W. H., Mattocks, A. R., Bownes, J. M.: Lesions in the liver and lungs of rats given pyrrole derivatives of pyrrolizidine alkaloids. J. Path. 100, 169–175 (1970).PubMedCrossRefGoogle Scholar
  82. Buu-Hoi, N. P.: New developments in chemical carcinogenesis by polycyclic hydrocarbons and related heterocycles. A review. Cancer Res. 24, 1511–1523 (1964).Google Scholar
  83. Buu-Hoi, N.P., Sung, S.S.: A non-radiative photochemical model for polycyclic aromatic hydrocarbon-induced carcinogenesis. Naturwissenschaften 57, 135–136 (1970).PubMedCrossRefGoogle Scholar
  84. Calvin, M.: Carcinogenesis: chemical and otherwise. Radiat. Res. 50, 105–119 (1972).PubMedCrossRefGoogle Scholar
  85. Campbell, T.C., Caedo, J. P., Jr., Bulatao-Jayme, J., Salamat, L., Engle, R.W.: Aflatoxin MI in human urine. Nature (Lond.) 227, 403–404 (1970).CrossRefGoogle Scholar
  86. Caspersson, T., Zech, L., Modest, E. J., Foley, G. E., Wagh, U., Simonsson, E.: Chemical differen-tiation with fluorescent alkylating agents in Vicia Faba metaphase chromosomes. Exp. Cell Res. 58, 128–140 (1969).PubMedCrossRefGoogle Scholar
  87. Cavalieri, E., Auerbach, R.: Charge localisation in the carbonium ion of benzpyrenes and methyl benzanthracenes. Coupling with nucleophilic compounds. Proc. Amer. Ass. Cancer Res. 14, 123 (1973).Google Scholar
  88. Cavalieri, E., Calvin, M.: Molecular characteristics of some carcinogenic hydrocarbons. Proc. nat. Acad. Sci. (Wash.) 68, 1251–1253 (1971a).CrossRefGoogle Scholar
  89. Cavalieri, E., Calvin, M.: Photochemical coupling of benzo(a)pyrene with 1 methylcytosine: pho- toenhancement of carcinogenicity. Photochem. Photobiol. 14, 641–653 (1971b).PubMedCrossRefGoogle Scholar
  90. Clapp, N.K., Craig, A.W., Toya, R.E.: Oncogenicity by methyl methanesulfonate in male RF mice. Science 161, 913–914 (1968).PubMedCrossRefGoogle Scholar
  91. Clayson, D.B.: Chemical carcinogenesis. London, England: J. and A. Churchill 1962.Google Scholar
  92. Clayson, D.B., Cooper, E.H.: Cancer of the urinary tract. Advanc. Cancer Res. 13, 271–381 (1970).CrossRefGoogle Scholar
  93. Clayson, D.B., Dawson, K.M., Dean, H.G.: Aromatic amine carcinogenesis: The importance of N-hydroxylation. Xenobiotica 1, 539–542 (1971).PubMedCrossRefGoogle Scholar
  94. Clifford, J.I., Rees, K.R.: Aflatoxin: A site of action in the rat liver cell. Nature (Lond.) 209, 312–313 (1966).CrossRefGoogle Scholar
  95. Clifford, J. I., Rees, K.R.: The interaction of aflatoxins with purines and purine nucleosides. Bio- chem. J. 103, 467–471 (1967).Google Scholar
  96. Clifford, J.E., Rees, K.R.: Investigations on the nature of the binding of aflatoxin Bx with DNA. Biochem. Pharmacol. 18, 2783–2785 (1969).PubMedCrossRefGoogle Scholar
  97. Clifford, J. I., Rees, K.R., Stevens, M.E.M.: The effect of the aflatoxins Bu Gx and G2 on protein and nucleic acid synthesis in rat liver. Biochem. J. 103, 258–261 (1967).PubMedGoogle Scholar
  98. Colburn, N.H., Boutwell, R.K.: The binding of ß-propiolactone to mouse skin DNA in vivo; its correlation with tumor-initiating activity. Cancer Res. 26, 1701–1706 (1966).PubMedGoogle Scholar
  99. Colburn, N.H., Boutwell, R.K.: In vivo binding of ß-propiolactone to mouse skin DNA, RNA and protein. Cancer Res. 28, 642–652 (1968).PubMedGoogle Scholar
  100. Colburn, N.H., Richardson, R.G., Boutwell, R.K.: Studies of the reaction of /?-propiolactone with deoxyguanosine and related compounds. Biochem. Pharmacol. 14, 1113–1118 (1965).PubMedCrossRefGoogle Scholar
  101. Cook, J. W., Duffy, E., Schoental, R.: Primary liver tumours in rats following feeding with alkaloids of Senecio Jacobea. Brit. J. Cancer 4, 405–410 (1950).PubMedCrossRefGoogle Scholar
  102. Cook, J. W., SCHOENTAL, R.: Oxidation of carcinogenic hydrocarbons by osmium tetroxide. J. chem. Soc. p. 170–173 (1948).Google Scholar
  103. Cookson, M. J., Sims, P., Grover, P.L.: Mutagenicity of epoxides of polycyclic hydrocarbons correlates with carcinogenicity of parent hydrocarbons. Nature (Lond.) New Biol. 234, 186–187 (1971).Google Scholar
  104. Corbett, T.H., Heidelberger, C., Dove, W.F.: Determination of the mutagenic activity to bacteriophage T 4 of carcinogenic and noncarcinogenic compounds. Molec. Pharmacol. 6, 667–679 (1970).Google Scholar
  105. Craddock, V.M.: Reaction of the carcinogen dimethylnitrosamine with proteins and with thiol compounds in the intact animal. Biochem. J. 94, 323–330 (1965).PubMedGoogle Scholar
  106. Craddock, V.M.: Transfer RNA methylases and cancer. Nature (Lond.) 228, 1264–1268 (1970).CrossRefGoogle Scholar
  107. Craddock, V. M., Magee, P. N.: Reaction of the carcinogen dimethylnitrosamine with nucleic acids in vivo. Biochem. J. 89, 32–37 (1963).PubMedGoogle Scholar
  108. Craig, A.M., Isenberg, I.: Binding of polycyclic aromatic hydrocarbons to polyadenylic acid. Proc. nat. Acad. Sci. (Wash.) 67, 1337–1344 (1970).CrossRefGoogle Scholar
  109. Cramer, J.W., Miller, J.A., Miller, E.C.: N-hydroxylation: A new metabolic reaction observed in the rat with the carcinogen 2-acetylaminoflurorene. J. biol. Chem. 235, 885–888 (1960).PubMedGoogle Scholar
  110. Crook, L.E., Harley, E.H., Cohen, A., Rees, K.R.: The mechanism of action of aflatoxin Bx: observations on virus infected cells. Chem. Biol. Interactions 5, 107–116 (1972).CrossRefGoogle Scholar
  111. Culvenor, C.C. J., Dann, A.T., Dick, A.T.: Alkylation as the mechanism by which the hepatotoxic pyrrolizidine alkaloids act on cell nuclei. Nature (Lond.) 195, 570–573 (1962).CrossRefGoogle Scholar
  112. Culvenor, C.C. J., Downing, D.T., Edgar, J. A., Jago, M. V.: Pyrrolizidine alkaloids as alkylating and antimitotic agents. Ann. N. Y. Acad. Sci. 163, 837–847 (1969).CrossRefGoogle Scholar
  113. Culvenor, C.C.J., Edgar, J.A., Smith, L.W., Jago, M.V., Peterson, J.E.: Active metabolites in the chronic hepatotoxicity of pyrrolizidine alkaloids, including otonecine esters. Nature (Lond.) New Biol. 229, 255–256 (1971).CrossRefGoogle Scholar
  114. Cusachs, L.C., Steele, R.H.: A consideration of the possible role of electronically excited singlet molecular oxygen in carcinogenesis. In: Physico-chemical mechanisms of carcinogenesis, p. 59–63, ed. Bergmann, E.D., and Pullman, B. The Jerusalem Symposia on Quantum Chemistry and Biochemistry, Vol. 1, Israel Academy of Sciences and Humanities 1969.Google Scholar
  115. Dale, M.M., Hedges, J.R.: The effect of carcinogens on immune responses in the guinea-pig. Brit. J. exp. Path. 54, 437–448 (1973).PubMedGoogle Scholar
  116. Dalezios, J.I., Wogan, G. N.: Metabolism of aflatoxin Bx in rhesus monkeys. Cancer Res. 32, 2297–2303 (1972).PubMedGoogle Scholar
  117. Dalezios, J., Wogan, G. N., Weinreb, S. M.: Aflatoxin: A new aflatoxin metabolite in monkeys. Science 171,584–585 (1971).PubMedCrossRefGoogle Scholar
  118. Daly, J.W., Jerina, D.M., Witkop, B.: Arene oxides and the NIH shift: the metabolism, toxicity and carcinogenicity of aromatic compounds. Experientia (Basel) 28, 1129–1149 (1972).CrossRefGoogle Scholar
  119. Daudel, P., Daudel7, R.: Chemical carcinogenesis and molecular biology. New York: Interscience publishers 1966.Google Scholar
  120. Davidson, J.: The action of retrorsine on rats liver. J. Path. Bact. 40, 285–295 (1935).CrossRefGoogle Scholar
  121. Dawson, K.M.: Time course of the effects of AAF on mouse liver nucleic acid synthesis and its modification by inhibitors. Chem-Biol. Interactions. 5, 153–165 (1972).Google Scholar
  122. Debaun, J.R., MILLER, E.C., MILLER, J.A.: 7V-Hydroxy-2-acetylaminofluorene Sulfotransferase: Its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat liver. Cancer Res. 30, 577–595 (1970a).PubMedGoogle Scholar
  123. Debaun, J. R., Rowley, J. Y., Miller, E. C, Miller, J. A.: Sulfotransferase activation of TV-Hydroxy- 2-acetylaminofluorene in rodent livers susceptible and resistant to the carcinogen. Proc. Soc. exp. Biol. (N. Y.) 129, 268–273 (1968).Google Scholar
  124. Debaun, J.R., Smith, J.Y.R., Miller, E.C., Miller, J.A.: Reactivity in vivo of the carcinogen N-hydroxy-2-acetylaminofluorene: Increased by sulfate ion. Science 167, 184–186 (1970b).PubMedCrossRefGoogle Scholar
  125. Denlinger, R.H., Swenberg, J.A., Koestner, A., Wechsler, W.: Differential effect of immuno-suppression on the induction of nervous system and bladder tumours by N-methyl-N-nitrosourea. J. nat. Cancer Inst. 50, 87–93 (1974)Google Scholar
  126. Derecondo, A. M., Frayssinet, C., Lafarge, C, Lebreton, E.: Action de l’aflatoxine sur le metabolisms du RNA au cours de l’hypertrophie compensatrice du foie après hépatectomie partielle. Biochim. biophys. Acta (Amst.) 119, 322–330 (1966).Google Scholar
  127. Detroy, R. W., Hesseltine, C. W.: Isolation and biological activity of a microbial conversion product of aflatoxin B,. Nature (Lond.) 219, 967 (1968).CrossRefGoogle Scholar
  128. Detroy, R. W., Hesseltine, C. W.: Aflatoxicol: Structure of a new transformation product of aflatoxin Bp Canad. J. Biochem. 48, 830–832 (1970).Google Scholar
  129. Diamond, L., Defendi, V., Brookes, P.: The interaction of 7,12-dimethylbenz(a)anthracene with cells sensitive and resistant to toxicity induced by this carcinogen. Cancer Res. 27, 890–897 (1967).PubMedGoogle Scholar
  130. Diamond, L., Gelboin, H.V.: Alpha-naphthoflavone: an inhibitor of hydrocarbon cytotoxicity and microsomal hydroxylase. Science 166, 1023–1025 (1969).PubMedCrossRefGoogle Scholar
  131. Diamond, L., Mcfall, R., Miller, J., Gelboin, H.V.: The effects of two isomeric benzoflavones on aryl hydrocarbon hydroxylase and the toxicity and carcinogenicity of polycyclic hydrocarbons. Cancer Res. 32, 731–736 (1972).PubMedGoogle Scholar
  132. Dickens, F.: Carcinogenic lactones and related substances. Brit. med. Bull. 20, 96–101 (1964).PubMedGoogle Scholar
  133. Dickens, F., Jones, H.E.H.: Carcinogenic activity of a series of reactive lactones and related substances. Brit. J. Cancer 15, 85–100 (1961).PubMedCrossRefGoogle Scholar
  134. Dickens, F., Jones, H.E.H.: Further studies on the carcinogenic action of certain lactones and related substances in the rat and mouse. Brit. J. Cancer 19, 392–403 (1965).PubMedCrossRefGoogle Scholar
  135. Dipaolo, J. A., Donovan, P. J., Nelson, R. L.: Transformation of hamster cells in vitro by polycyclic hydrocarbons without cytotoxicity. Proc. nat. Acad. Sci. (Wash.) 68, 2958–2961 (1971).CrossRefGoogle Scholar
  136. Dipple, A., Brookes, P., Macintosh, D.S., Rayman, M.P.: Reaction of 7-bromomethylbenz(a)an- thracene with nucleic acids, polynucleotides and nucleosides. Biochemistry 10, 4323–4330 (1971).PubMedCrossRefGoogle Scholar
  137. Dipple, A., Lawley, P.D., Brookes, P.: Theory of tumour initiation by chemical carcinogens: dependence of activity on structure of ultimate carcinogen. Europ. J. Cancer 4, 493–506 (1968).CrossRefGoogle Scholar
  138. Dipple, A., Slade, T. A.: Structure and activity in chemical carcinogenesis: reactivity and carcinogenicity of 7-bromomethylbenz(a)anthracene and 7-bromomethyl-12-methylbenz(a)anthracene. Europ. J. Cancer 6, 417–423 (1970).CrossRefGoogle Scholar
  139. Diringer, H., HEIDELBERGER, C.: 2-phenylphenanthrene-3,2/-dicarboxylic acid is not bound to mouse skin proteins after application of 1,2,5,6 dibenzanthracene: a retraction. Cancer Res. 29,2127–2128 (1969).PubMedGoogle Scholar
  140. Dost, F.W., Reed, D.J.: Methane formation in vivo from N-isopropyl(2-methylhydrazine)-p-tolu- amide hydrochloride a tumor-inhibiting methylhydrazine derivative. Biochem. Pharmacol. 16, 1741–1746(1967).PubMedCrossRefGoogle Scholar
  141. Dost, F. W., Reed, D. J., Wang, C. H.: The metabolic fate of monomethylhydrazine and unsymmetri- cal dimethylhydrazine. Biochem. Pharmacol. 15, 1325–1332 (1966).CrossRefGoogle Scholar
  142. Druckrey, H.: Quantitative aspects in chemical carcinogenesis. In: Potential carcinogenic hazards from drugs, ed. Truhaut, R., p. 60–78. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  143. Druckrey, H.: Production of colonic carcinomas by 1,2-dialkylhydrazines and azoxyalkanes. IN: Carcinoma of the colon and antecedent epithelium, ed. Burdette, W.J., p. 267–279. Springfield: Charles C. Thomas 1970.Google Scholar
  144. Druckrey, H.: Gegenwärtiger Stand der Krebsforschung. Ärztl. Prax. 24, 2537–2540, 2593–2596, 2621–2622(1972).Google Scholar
  145. Druckrey, H., Ivankovic, S., Preussman, R.: Selektive Erzeugung maligner Tumoren im Gehirn und Rückenmark von Ratten durch N-Methyl-N-nitrosoharnstoff. Z. Krebsforsch. 66, 389–408 (1965a).PubMedCrossRefGoogle Scholar
  146. Druckrey, H., Ivankovic, S., Preussman, R.: Neurotrope carcinogene Wirkung von Phenyl-dime- thyltriazen an Ratten. Naturwissenschaften 54, 171 (1967a).PubMedCrossRefGoogle Scholar
  147. Druckrey, H., Ivankovic, S., Preussman, R.: Selektive Erzeugung von Carcinomen des Drusen-magens bei Ratten durch orale Gabe von N-Methyl-N-Nitroso-Nr-Acetylharnstoff (AcMNH). Z. Krebsforsch. 75, 23–33 (1970a).PubMedCrossRefGoogle Scholar
  148. Druckrey, H., Ivankovic, S., Preussman, R., Landschutz, C., Stekar, J., Brunner, U., Schagen, B.: Transplacental induction of neurogenic malignomers by 1,2-diethylhydrazine, azo- and azoxy- ethane in rats. Experientia (Basel) 24, 561–562 (1968a).CrossRefGoogle Scholar
  149. Druckrey, H., Kruse, H., Preussman, R., Ivankovic, S., Landschutz, C.: Carcinogene alkylierende Substanzen. III. Alkyl-halogenide, -sulfate, -sulfonate und ringgespannte Heterocyclen. Z. Krebs- forsch. 74, 241–270 (1970b).CrossRefGoogle Scholar
  150. Druckrey, H., Kruse, H., Preussman, R., Ivankovic, S., Landschutz, C., Gimmy, J.: Carcinogene alkylierende Substanzen. IV. 1,3-Propansulton und 1,4-Butansulton. Z. Krebsforsch. 75, 69–84 (1970c).PubMedCrossRefGoogle Scholar
  151. Druckrey, H., Landschutz, C., Ivankovic, S.: Transplacentare Erzeugung maligner Tumoren des Nervensystems. II. Äthylnitrosoharnstoff an I O genetischdefinierten Rattenstämmen. Z. Krebsforsch. 73, 371–386 (1970d).PubMedCrossRefGoogle Scholar
  152. Druckrey, H., Lange, A.: Carcinogenicity of azoxymethane dependent on age in BD rats. Fed. Proc. 31, 1482–1484(1972).PubMedGoogle Scholar
  153. Druckrey, H., Preussman, R., BÜCheler, J., Ivankovic, S.: Carcinogene alkylierende Substanzen. II. Bis-(morpholino-)methan. Z. Krebsforsch. 71, 105–108 (1968b).PubMedCrossRefGoogle Scholar
  154. Druckrey, H., Preussman, R., Ivankovic, S., SCHMÄHl, D.: Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten. Z. Krebsforsch. 69, 103–201 (1967b).PubMedCrossRefGoogle Scholar
  155. Druckrey, H., Preussman, R., Ivankovic, S., Schmidt, C.H., Mennel, H.D., Stahl, K.W.: Selektive Erzeugung von Blasenkrebs an Ratten durch Dibutyl- und N-Butyl-N-butanol(4)-nitrosa- min. Z. Krebsforsch. 66, 280–290 (1964).PubMedCrossRefGoogle Scholar
  156. Druckrey, H., Preussman, R., Ivankovic, S., Schmidt, C.H., So, B.T., Thomas, C: Carcinogene Wirkung von Azoäthan und Azoxyäthan an Ratten. Z. Krebsforsch. 67, 31–45 (1965b).PubMedCrossRefGoogle Scholar
  157. Druckrey, H., Preussman, R., Matzkies, F., Ivankovic, S.: Carcinogene Wirkung von 1,2-Diäthyl- hydrazin an Ratten. Naturwissenschaften 53, 557–558 (1966a).CrossRefGoogle Scholar
  158. Druckrey, H., Preussman, R., Matzkies, F., Ivankovic, S.: Selektive Erzeugung von Darm-Krebs bei Ratten durch 1,2-dimethyl-hydrazin. Naturwissenschaften 54, 285–286 (1967c).PubMedCrossRefGoogle Scholar
  159. Druckrey, H., Preussman, R., Nashed, N., Ivankovic, S.: Carcinogene alkylierende Substanzen. 1. Dimethylsulfat, carcinogene Wirkung an Ratten und wahrscheinliche Ursache von Berufskrebs. Z. Krebsforsch. 68, 103–107 (1966b).PubMedCrossRefGoogle Scholar
  160. Druckrey, H., Preussman, R., SCHMÄHl, D., MÜLler, M.: Erzeugung von Magenkrebs durch Nitrosamide an Ratten. Naturwissenschaften 48, 165 (1961a).CrossRefGoogle Scholar
  161. Druckrey, H., Preussman, R., SCHMÄHl, D., MÜLler, M.: Chemische Konstitution und Carcinogene Wirkung bei Nitrosaminen. Naturwissenschaften 48, 134–135 (1961b).CrossRefGoogle Scholar
  162. Druckrey, H., Steinhoff, D., Preussman, R., Ivankovic, S.: Krebserzeugung durch einmalige Dosis von Methylnitrosoharnstoff und verschiedenen Dialkyl-nitrosaminen. Naturwissenschaften 50, 735 (1963).CrossRefGoogle Scholar
  163. Duncan, M. E., Brookes, P.: The relation of metabolism to macromolecular binding of the carcinogen benzo(a)pyrene by mouse embryo cells in culture. Int. J. Cancer 6, 496–505 (1970).PubMedCrossRefGoogle Scholar
  164. Duncan, M.E., Brookes, P.: Metabolism and macromolecular binding of dibenz(a,c)anthracene and dibenz(a,h)anthracene by embryo cells in culture. Int. J. Cancer 9, 349–352 (1972).PubMedCrossRefGoogle Scholar
  165. Duncan, M., Brookes, P., Dipple, A.: Metabolism and binding to cellular macromolecules of a series of hydrocarbons by mouse embryo cells in culture. Int. J. Cancer 4, 813–819 (1969).PubMedCrossRefGoogle Scholar
  166. Dunning, W.F., Curtis, M.R.: Relative carcinogenic activity of monomethyl derivatives of benz(a)- anthracene in Fischer line 344 rats. J. nat. Cancer Inst. 25, 387–391 (1960).Google Scholar
  167. Dutton, C.J.: Glucuronide forming enzymes. In: Handbuch der experimentellen Pharmakologie, vol. 28, pt. 2, ed. Brodie, B.B., and J.R. Gillette, p. 378–400. Berlin-Heidelberg-New York: Springer 1971.Google Scholar
  168. Dutton, M.F., Heathcote, J.G.: The structure, biochemical properties and origin of the aflatoxins B2a and G2a. Chem. Ind. (Lond.)3 418–421 (1968).Google Scholar
  169. Edwards, G.S., Wogan, G.N.: Aflatoxin inhibition of template activity of rat liver chromatin. Biochim. biophys. Acta (Amst.) 224, 596–607 (1970).Google Scholar
  170. Edwards, G.S., Wogan, G.N., Sporn, M.B., Pong, R.S.: Structure-activity relationships in DNA binding and nuclear effects of aflatoxin and analogs. Cancer Res. 31, 1943–1950 (1971).PubMedGoogle Scholar
  171. Endo, H., Ono, T., Sugimura, T.: Recent results in cancer research: Chemistry and biological action of 4-nitroquinoline 1-oxide. Berlin-Heidelberg-New York: Springer 1971.Google Scholar
  172. Endo, H., Kume, F.: Induction of sarcoma in rats by a single injection of 4-hydroxyaminoquinoline-l- oxide. Gann 56, 261–265 (1965).PubMedGoogle Scholar
  173. Engelbrecht, J.C., Altenkirk, B.: Comparison of some biological effects of sterigmatocystin and aflatoxin analogs on primary cell cultures. J. nat. Cancer Inst. 48, 1647–1655 (1972).PubMedGoogle Scholar
  174. Enomoto, M., Sato, K., Miller, E.C., Miller, J.A.: Reactivity of the diacetyl derivative of the carcinogen 4-hydroxyaminoquinoline-l-oxide with DNA, RNA, and other nucleophiles. Life Sci. 7, 1025–1032 (1968).CrossRefGoogle Scholar
  175. Epstein, S.M., Mcnary, J., Bartus, B., Farber, E.: Chemical carcinogenesis: Persistence of bound forms of 2-fluorenylacetamide. Science 162, 907–908 (1968).PubMedCrossRefGoogle Scholar
  176. Ernster, L., Danielson, L., Ljunggren, J.: DT diaphorase. 1. Purification from the soluble fractions of rat liver cytoplasm and properties. Biochim. biophys. Acta (Amst.) 58, 171–188 (1962).CrossRefGoogle Scholar
  177. Fahmy, O.G., Fahmy, M.J.: Gene elimination in carcinogenesis. Reinterpretation of the somatic mutation theory. Cancer Res. 30, 195–205 (1970).PubMedGoogle Scholar
  178. Fahmy, O.G., Fahmy, M.J.: Mutagenic selectivity for the RNA forming genes in relation to the carcinogenicity of alkylating agents and polycyclic aromatics. Cancer Res. 32, 550–557 (1972).PubMedGoogle Scholar
  179. Fahmy, O.G., Fahmy, M.J.: Mutagenic properties of benzo(a)pyrene and its methylated derivatives in relation to the molecular mechanisms of hydrocarbon carcinogenesis. Cancer Res. 33, 302–309 (1973).PubMedGoogle Scholar
  180. Falk, H.L., Kotin, P., Lee, S.S., Nathan, A.: Intermediary metabolism of benzo(a)pyrene in the rat. J. nat. Cancer Inst. 28, 699–724 (1962).Google Scholar
  181. Farber, E.: Ethionine carcinogenesis. Advanc. Cancer Res. 7, 383–474 (1963).CrossRefGoogle Scholar
  182. Farber, E.: Biochemistry of carcinogenesis. Cancer Res. 28, 1859–1869 (1968).PubMedGoogle Scholar
  183. Farber, E., Mcconomy, J., Franzen, B., Marroquin, F., Stewart, G. A., Magee, P.N.: Interaction between ethionine and rat liver ribonucleic acid and protein in vivo. Cancer Res. 27, 1761–1772 (1967a).PubMedGoogle Scholar
  184. Farber, E., Mcconomy, J., Frumanski, B.: Relative degrees of labelling of liver DNA and RNA with ethionine. Proc. Amer. Ass. Cancer Res. 8, 16 (1967b).Google Scholar
  185. Farber, E., Magee, P. N.: The probable alkylation of liver ribonucleic acid by the hepatic carcinogens dimethylnitrosamine and ethionine. Biochem. J. 76, 58P (1960).Google Scholar
  186. Farber, E., Shull, K.H., VILLA-Trevino, S., Thomas, M.: Biochemical pathology of acute hepatic adenosinctriphosphatc deficiency. Nature (Lond.) 203, 34–40 (1964).CrossRefGoogle Scholar
  187. Fieser, L. F.: Carcinogenic activity, structure and chemical reactivity of polycyclic aromatic hydrocar-bons. Amer. J. Cancer 34, 37–124 (1938).Google Scholar
  188. Fink, L., Flieg, A., Grunberger, D., Weinstein, I.B.: Effects of IV-2-Acetylaminofluorene (AAF) modification of nucleic acids on their secondary structure. Proc. Amer. Ass. Cancer Res. 12, 11 (1971).Google Scholar
  189. Fink, L.M., Nishmura, S., Weinstein, I.B.: Modification of RNA by chemical carcinogens. I. in vitro modification of transfer RNA by 7V-acetoxy-2-acetylaminofluorene. Biochemistry 9, 496–502 (1970).PubMedCrossRefGoogle Scholar
  190. Fiume, L.: Azione inibente deH’aminoacetonitrile sulla degenerazione idropica e sulla necrosi prodotte dal cloroformio nel fígato e nel rene di ratto. Sperimentale 112, 365–375 (1962).PubMedGoogle Scholar
  191. Fiume, L., Campa-Dllifiume, G., Magee, P.N., Holsman, J.: Cellular injury and carcinogenesis. Inhibition of metabolism of dimethylnitrosamine by aminoacetonitrile. Biochem. J. 120, 601–605 (1970).PubMedGoogle Scholar
  192. Flesher, J. W., Sydnor, K.: Carcinogenicity of derivatives of 7,12-dimethylbenz(a)anthracene. Cancer Res. 31, 1951–1954(1971).Google Scholar
  193. Flesher, J.W., Sydnor, K.L.: Possible role of 6-hydroxymethylbenzo(a)pyrene as a proximate carcinogen of benzo(a)pyrene and 6-methylbenzo(a)pyrene. Int. J. Cancer 11, 433–437 (1973).PubMedCrossRefGoogle Scholar
  194. Floyd, L.R., Unuma, R., Busch, H.: Effects of aflatoxin BX and other carcinogens upon nuclear RNA of various tissues in the rat. Exp. Cell Res. 51, 423–438 (1968).PubMedCrossRefGoogle Scholar
  195. FreÍ, J. V.: Toxicity, tissue changes and tumor induction in inbred Swiss mice by methylnitrosamine- and -amide compounds. Cancer Res. 30, 11–17 (1970).PubMedGoogle Scholar
  196. FreÍ, J. V.: Tissue-dependent differences in DNA methylation products of mice treated with methyl- labelled methylnitrosourea. Int. J. Cancer 7, 436–442 (1971).PubMedCrossRefGoogle Scholar
  197. FreÍ, J. V., Ritchie, A.C.: Diurnal variation in the susceptibility of mouse epidermis to carcinogen and its relationship to DNA synthesis. J. nat. Cancer Inst. 32, 1213–1220 (1964).PubMedGoogle Scholar
  198. Freund, H.A.: Clinical manifestations and studies in parenchymatous hepatitis. Ann. intern. Med. 10, 1144–1155 (1937).Google Scholar
  199. Fried, J., Schumm, D.E.: One electron transfer oxidation of 7,12-dimethylbenz(a)anthracene, a model for the metabolic activation of carcinogenic hydrocarbons. J. Amer. chem. Soc. 89, 5508–5509 (1967).CrossRefGoogle Scholar
  200. Friedman, M.A., Wogan, G.N.: Effects of aflatoxin BJ on RNA polymerase activity and incorporation of cytidine into RNA of rat liver nuclei. Fed. Proc. 26, 358 (1967).Google Scholar
  201. Friedman, M.A., Wogan, G.N.: Liver nuclear RNA metabolism in rats treated with aflatoxin B Life Sci. 9, 741–747(1970).CrossRefGoogle Scholar
  202. Fukuda, S., Yamamoto, N.: Search for activating enzymes for proximal carcinogens using microbial assay systems. Proc. Amer. Ass. Cancer Res. 12, 42 (1971).Google Scholar
  203. Fukuda, S., Yamamoto, N.: Detection of activating enzymes for 4-nitroquinoline 1-oxide activation with a microbial assay system. Cancer Res. 32, 435–439 (1972).PubMedGoogle Scholar
  204. Gabridge, M. G., Denunzio, A., Legator, M. S.: Cycasin: Detection of associated mutagenic activity in vivo. Science 163, 689–691 (1969).PubMedCrossRefGoogle Scholar
  205. Ganóte, C.E., Rosenthal, A.S.: Characteristic lesions of methylazoxymethanol-induced liver damage. A comparative ultrastructural study with dimethylnitrosamine, hydrazine sulfate and carbon tetrachloride. Lab. Invest. 19, 382–398 (1968).PubMedGoogle Scholar
  206. Garner, R.C.: Microsome-dependent binding of aflatoxin B1 to DNA, RNA, polyribonucleotides and protein in vivo. Chem.-Biol. Interactions. 6, 125–129 (1973a).Google Scholar
  207. Garner, R.C.: Chemical evidence for the formation of a reactive aflatoxin BJ metabolite by hamster liver microsomes. FEBS Letters 36, 261–264 (1973b).PubMedCrossRefGoogle Scholar
  208. Garner, R.C., Miller, E.C., Miller, J.A.: Liver microsomal metabolism of aflatoxin BJ to a reactive intermediate toxic to Salmonella typhimurium TA 1530. Cancers Res. 32, 2058–2066 (1972).PubMedGoogle Scholar
  209. Garner, R.C., Miller, E.C., Miller J. A., Garner, J.V., Hanson, R.S.: Formation of a factor lethal for S. typhimurium TA 1530 and TA 1531 on incubation of aflatoxin Bj with rat liver microsomes. Biochem. biophys. Res. Commun. 45, 774–780 (1971).Google Scholar
  210. Gelboin, H. V.: A microsome dependent binding of benzo(a)pyrene to DNA. Cancer Res. 29, 1272–1276(1969).Google Scholar
  211. Gelboin, H. V., Huberman, E., Sachs, L.: Enzymatic hydroxylation of benzopyrene and its relationship to cytotoxicity. Proc. nat. Acad. Sci. (Wash.) 64, 1188–1194 (1969).CrossRefGoogle Scholar
  212. Gelboin, H.V., Klein, M.: Skin tumorigenesis by 7,12 dimethylbenz(a)anthracene: inhibition by actinomycin D. Science 145, 1321–1322 (1964).PubMedCrossRefGoogle Scholar
  213. Gelboin, H.V., Klein, M., Bates, R.R.: Inhibition of mouse skin tumorigenesis by actinomycin D. Proc. nat. Acad. Sci. (Wash.) 53, 1353–1360 (1965).CrossRefGoogle Scholar
  214. Gelboin, H. V., Wiebel, F. J., Diamond, L.: Dimethylbenzanthracene tumorigenesis and aryl hydrocarbon hydroxylase in mouse skin: inhibition by 7,8 benzoflavone. Science 170, 169–171 (1970).PubMedCrossRefGoogle Scholar
  215. Gelboin, H.V., Wortham, J.S., Wilson, R.G., Friedman, M., Wogan, G.N.: Rapid and marked inhibition of rat liver RNA polymerase by aflatoxin Science 154, 1205–1206 (1966).PubMedCrossRefGoogle Scholar
  216. Gerchman, L. L., Ludlum, D. B.: The properties of 06-methylguanine in templates for RNA polymerase. Biochim. biophys. Acta (Amst.) 308, 310–316 (1973).Google Scholar
  217. Goodall, C.M., Butler, W.H.: Aflatoxin carcinogenesis: Inhibition of liver cancer induction in hypophysectomised rats. Int. J. Cancer 4, 422–429 (1969).PubMedCrossRefGoogle Scholar
  218. Goodman, J.I., Potter, V.R.: Early effects of 3/-methyl-4-dimethylaminoazobenzene (MeDAB) administration: Evidence of an increased turnover of hepatic DNA. Proc. Amer. Ass. Cancer Res. 12, 36 (1971).Google Scholar
  219. Goodman, J. I., Potter, V. R.: Evidence for DNA repair synthesis and turnover in rat liver following injection of 3/-methyl-4-dimethylaminoazobenzene. Cancer Res. 32, 766–775 (1972).PubMedGoogle Scholar
  220. Goshman, L.M., Heidelberger, C.: Binding of tritium labelled polycyclic hydrocarbons to DNA of mouse skin. Cancer Res. 27, 1678–1688 (1967).PubMedGoogle Scholar
  221. Goth, R., Rajewsky, M.F.: Ethylation of nucleic acids by ethylnitrosourea-l-14C in the fetal and adult rat. Cancer Res. 32, 1501–1505 (1972).PubMedGoogle Scholar
  222. Goth, R., Rajewsky, M.F.: Persistence of 06-ethylguanine in rat brain DNA: correlation with nervous system specific carcinogenesis by ethylnitrosourea. Proc. nat. Acad. Sei (Wash.) 71, 639–643 (1974).CrossRefGoogle Scholar
  223. Grasso, P., Creasey, M.: Carcinoma of the colon in a rat. Europ. J. Cancer 5, 415–419 (1969).CrossRefGoogle Scholar
  224. Grice, H.C., Moodie, C. A., Smith, D.C.: The carcinogenic potential of aflatoxin or its metabolites in rats from dams fed aflatoxin pre- and postpartum. Cancer Res. 33, 262–268 (1973).PubMedGoogle Scholar
  225. Grover, P.L., Forrester, J. A., Sims, P.: Reactivity of the K-region epoxides of some polycyclic hydrocarbons towards the nucleic acids and proteins of BHK 21 cells. Biochem. Pharmacol. 20, 1297–1302 (1971b).PubMedCrossRefGoogle Scholar
  226. Grover, P. L., Hewer, A., Sims, P.: Epoxides as microsomal metabolites of polycyclic hydrocarbons. FEBS Letters 18, 76–80 (1971b).PubMedCrossRefGoogle Scholar
  227. Grover, P.L., Hewer, A., Sims, P.: Formation of K-region epoxides as microsomal metabolites of pyrene and benzo(a)pyrene. Biochem. Pharmacol. 21, 2713–2726 (1972).PubMedCrossRefGoogle Scholar
  228. Grover, P. L., Sims, P.: Enzyme catalysed reactions of polycyclic hydrocarbons with deoxyribonucleic acid and protein in vitro. Biochem. J. 110, 159–160 (1968).PubMedGoogle Scholar
  229. Grover, P. L., Sims, P.: Interactions of the K-region epoxides of phenanthrene and dibenz(a,h)anthra- cene with nucleic acids and histone. Biochem. Pharmacol. 19, 2251–2259 (1970).PubMedCrossRefGoogle Scholar
  230. Grover, P.L., Sims, P., Huberman, E., Marquardt, H., Kuroki, T., Heidelberger, C.: in vitro transformation of rodent cells by K region derivatives of polycyclic hydrocarbons. Proc. nat. Acad. Sci. (Wash.) 68, 1098–1101 (1971c).CrossRefGoogle Scholar
  231. Grunberger, D., Nelson, J.H., Cantor, C. R., Weinstein, I. B.: Coding and conformational properties of oligonucleotides modified with the carcinogen jV-2-acetylaminofluorene. Proc. nat. Acad. Sci. (Wash.) 66, 488–494 (1970).CrossRefGoogle Scholar
  232. Gryschek, G., Pasternak, G.: Die immunosuppressive Wirkung der leukämogenen Verbindung N-Methyl-N-Nitrosoharnstoff bei der Maus. Acta biol. med. germ. 27, 195–200 (1971).PubMedGoogle Scholar
  233. Guroff, G., Daly, J.W., Jerina, D.M., Renson, J., Witkop, B., Udenfriend, S.: Hydroxylation induced migration: the N.I.H. Shift. Science 157, 1524–1530 (1967).Google Scholar
  234. Gurtoo, H.L.: On the binding of aflatoxin Bj and its metabolite to hepatic microsomes. Biochem. biophys. Res. Commun. 50, 649–655 (1973).Google Scholar
  235. Gusek, W.: Feinstruktur und Differenzierung experimenteller Wilmstumoren. Verh. dtsch. Ges. Path. 52,410–415 (1968).Google Scholar
  236. Gusek, W., Buss, H., KRÜGer, C.H.: Morphologische und histochemische Befunde an experimentellen Nierentumoren der Ratte. Verh. dtsch. Ges. Path. 50, 337–343 (1966).Google Scholar
  237. Gusek, W., Buss, H., Laqueur, G.L.: Histologisch-histochemische Untersuchungen am “Interstitiellen Cycasin-Tumor” der Rattenniere. Beitr. path. Anat. 135, 53–74 (1967).Google Scholar
  238. Gutmann, H. R., Galitski, S. B., Foley, W. A.: The conversion of noncarcinogenic aromatic amides to carcinogenic arylhydroxamic acids by synthetic /V-hydroxylation. Cancer Res. 27, 1443–1455 (1967).PubMedGoogle Scholar
  239. Gutmann, H.R., Leaf, D.S., Yost, Y., Rydell, R.E., Chen, C.C.: Structure-activity relationships of iV-acylaryl-hydroxylamines in the rat. Cancer Res. 30, 1485–1498 (1970).PubMedGoogle Scholar
  240. Haerlin, R., SÜSsmuth, R., Lingens, F.: Mechanism of mutagenesis by N-methyl-N’-nitro-N-nitroso- guanidine (MNNG). V. Methylation of DNA by N-trideuteriomethyl-N’-nitro-N-nitrosoguani- dine (D3-MNNG). FEBS Letters 9, 175–176 (1970).PubMedCrossRefGoogle Scholar
  241. Halver, J. E.: Aflatoxicosis and rainbow trout hepatoma, p. 209–230. In: G.N. Wogan (ed.), Myco- toxins in foodstuffs. Cambridge, Mass.: M.I.T. Press 1965.Google Scholar
  242. Halver, J. E.: Aflatoxicosis and trout hepatoma. In: L. A. Goldblatt (ed.), Aflatoxin-scientific background control, and implications, p. 265–306. New York: Academic Press Inc. 1969.Google Scholar
  243. Hard, G.C., Butler, W.H.: Cellular analysis of renal neoplasia: induction of renal tumors in dietary-conditioned rats by dimethylnitrosamine, with a reappraisal of morphological characteristics. Cancer Res. 30, 2796–2805 (1970a).PubMedGoogle Scholar
  244. Hard, G.C., Butler, W.H.: Cellular analysis of renal neoplasia: light microscope study of the development of interstitial lesions induced in the rat kidney by a single carcinogenic dose of dimethylnitrosamine. Cancer Res. 30, 2806–2815 (1970b).PubMedGoogle Scholar
  245. Hard, G. C., Butler, W. H.: Toxicity of dimethylnitrosamine for the rat testis. J. Path. 102, 201–207 (1970c).PubMedCrossRefGoogle Scholar
  246. Hard, G.C., Butler, W.H.: Ultrastructural study of the development of interstitial lesions leading to mesenchymal neoplasia induced in the rat renal cortex by dimethylnitrosamine. Cancer Res. 31, 337–347 (1971a).PubMedGoogle Scholar
  247. Hard, G.C., Butler, W.H.: Ultrastructural analysis of renal mesenchymal tumor induced in the rat by dimethylnitrosamine. Cancer Res. 31, 348–365 (1971b).PubMedGoogle Scholar
  248. Hard, G.C., Butler, W. H.: Ultrastructural aspects of renal adenocarcinoma induced in the rat by dimethylnitrosamine. Cancer Res. 31, 366–372 (1971c).PubMedGoogle Scholar
  249. Harley, E.H., Rees, K.R., Cohen, A.: A comparative study of the effect of aflatoxin Bl and actinomycin D on Hela cells. Biochem. J. 114, 289–298 (1969).PubMedGoogle Scholar
  250. Harper, K. H.: The intermediary metabolism of polycyclic hydrocarbons. Brit. J. Cancer 13, 718–731 (1959).PubMedCrossRefGoogle Scholar
  251. Harris, H.: The use of cell fusion in the analysis of gene action. Proc. roy. Soc. B. 176, 315–317 (1970).CrossRefGoogle Scholar
  252. Harris, P.N., Chen, K.K.: Development of hepatic tumours in rats following ingestion of Senecio longilobus. Cancer Res. 30, 2881–2886 (1970).PubMedGoogle Scholar
  253. Hartman, P.E., Suskind, S.R.: Gene action, p. 145–206. Englewood Cliffs, New Jersey, U.S.A.: Prentice Hall Inc. 1965.Google Scholar
  254. Hartwell, J.L.: Survey of compounds which have been tested for carcinogenic activity. U. S. Public Health Service Publication 149, Washington DC, U.S.A. (1951Google Scholar
  255. Hashimoto, Y., Suzuki, E., Okada, M.: Induction of urinary bladder tumors in ACI/N rats by butyl (3-carboxypropyl)nitrosamine a major urinary metabolite of butyl (4-hydroxybutyl) nitros- amine. Gann 63, 637–638 (1972).PubMedGoogle Scholar
  256. Hashimoto, Y., Terasawa, M., Toriyama, N.: Metabolism of 4-Nitroquinoline N-Oxide. Seikagaku 36, 557(1964).Google Scholar
  257. Hawks, A., Farber, E., Magee, P. N.: Equilibrium centrifugation studies of colon DNA from mice treated with the carcinogen 1,2-dimethylhydrazine. Chem. Biol. Interactions 4, 144–148 (1971/72).CrossRefGoogle Scholar
  258. Hawks, A., Magee, P.N.: The alkylation of nucleic acids of rat and mouse in vivo by the carcinogen, 1,2-dimethylhydrazine. Brit. J. Cancer 30, 440–447 (1974).PubMedCrossRefGoogle Scholar
  259. Hawks, A., Swann, P.F., Magee, P.N.: Probable methylation of nucleic acids of mouse colon by 1,2-dimethylhydrazine in vivo. Biochem. Pharmacol. 21, 432–433 (1972).PubMedCrossRefGoogle Scholar
  260. Heath, D.F.: The decomposition and toxicity of dialkylnitrosamines in rats. Biochem. J. 85, 72–81 (1962).PubMedGoogle Scholar
  261. Heath, D.F.: Variations of microsomal oxidase activity in male rats as shown by rates of dimethylnitrosamine metabolism. Biochem. Pharmacol. 16, 1517–1521 (1967).PubMedCrossRefGoogle Scholar
  262. Heath, D.F., Dutton, A.: The detection of metabolic products from dimethylnitrosamine in rats and mice. Biochem. J. 70, 619–626 (1958).PubMedGoogle Scholar
  263. Hecker, E.: Isolation and characterisation of the cocarcinogenic principles from croton oil. Meth. Cancer Res. 6, 439–484(1971).Google Scholar
  264. Heidelberger, C.: Studies on the cellular and molecular mechanisms of hydrocarbon carcinogenesis. Europ. J. Cancer 6, 161–172 (1970a).CrossRefGoogle Scholar
  265. Heidelberger, C.: Chemical carcinogenesis, chemotherapy: Cancer’s continuing core challenges. — G.H. A. Clowes memorial lecture. Cancer Res. 30, 1549–1569 (1970b).PubMedGoogle Scholar
  266. Hennig, W., Kunz, W., Petersen, K., Schneiders, B., KRÜGer, F. W.: Characterisierung der durch Dimethylnitrosamin in vivo alkylierten RNS-Fractionen der Leber. Z. Krebsforsch. 76, 167–180 (1971).CrossRefGoogle Scholar
  267. Hennings, H., Boutwell, R.K.: On the mechanism of inhibition of benign and malignant skin tumour formation by actinomycin D. Life Sci. 6, 173–181 (1967).Google Scholar
  268. Hennings, H., Smith, H.C., Colburn, N.H., Boutwell, R.K.: Inhibition by actinomycin D of DNA and RNA synthesis and of skin tumorigenesis induced by 7,12-dimethylbenz(a)anthracene. Cancer Res. 28, 543–552 (1968).PubMedGoogle Scholar
  269. Heuson, J.C., Heimann, R.: Ibenzmethyzin (Natulan) a highly effective mammary carcinogen in the Huggins system. Europ. J. Cancer 2, 385–386 (1966).CrossRefGoogle Scholar
  270. Hicks, R.M., Wakefield, J.ST.J.: Rapid induction of bladder cancer in rats with N-methyl-N- nitrosourea. I. Histology. Chem. Biol. Interactions 5, 139–152 (1972).CrossRefGoogle Scholar
  271. Hirono, I., Hayashi, K., Mori, H., Miwa, T.: Carcinogenic effects of cycasin in Syrian golden hamsters and the transplantability of induced tumors. Cancer Res. 31, 283–287 (1971).PubMedGoogle Scholar
  272. Hirono, I., Laqueur, G.L., Spatz, M.: Tumor induction in Fischer and Osborne-Mendel rats by a single administration of cycasin. J. nat. Cancer Inst. 40, 1003–1010 (1968a).PubMedGoogle Scholar
  273. Hirono, I., Laqueur, G.L, Spatz, M: Transplantability of cycasin-induced tumors in rats with emphasis on nephroblastomas. J. nat. Cancer Inst. 40, 1011–1025 (1968b).PubMedGoogle Scholar
  274. Hirono, I., Shibuya, C.: High incidence of pulmonary tumors in dd mice by a single injection of cycasin. Gann 61, 403–407 (1970).PubMedGoogle Scholar
  275. Hirono, I., Shibuya, C., Fushimi, K.: Tumor induction in C57BL/6 mice by a single administration of cycasin. Cancer Res. 29, 1658–1662 (1969).PubMedGoogle Scholar
  276. Hochberg, A. A., Stratman, F.W., Zahlten, R.N., Morris, H.P., Lardy, H.A.: Binding of rat liver and hepatoma polyribosomes to stripped rough endoplasmic reticulum in vitro. Biological or artifact? Biochem. J. 130, 19–25 (1972).PubMedGoogle Scholar
  277. Hoffman, H. D., Lesko, S. A., Ts’O, P. O. P.: Chemical linkage of polycyclic hydrocarbons to deoxyri-bonucleic acids and polynucleotides in aqueous solution and in a buffer-ethanol solvent system. Biochemistry 9, 2594–2604 (1970).CrossRefGoogle Scholar
  278. Holtzman, J., Gillette, J. R., Milne, W.A.: The metabolic products of naphthalene in mammalian systems. J. Amer. chem. Soc. 89, 6341–6344 (1967).CrossRefGoogle Scholar
  279. Horisberger, M., Matsumoto, H.: Studies on methylazoxymethanol. Synthesis of 14Cand 3H labelled methylazoxymethylacetate. J. Labelled Compounds 4, 164–170 (1968).CrossRefGoogle Scholar
  280. Hrushesky, W., Sampson, D., Murphy, G.P.: Carcinogenicity of ethylmethanesulfonate. J. nat. Cancer Inst. 49, 1077–1083 (1972).PubMedGoogle Scholar
  281. Hsieh, D.P. H., Lin, M.T., Yao, R.C.: Conversion of Sterigmatocystin to aflatoxin Bx by Aspergillus Parasiticus. Biochem. biophys. Res. Commun. 52, 992–997 (1973).Google Scholar
  282. Huberman, E., Aspiras, L., Heidelberger, C., Grover, P.L., Sims, P.: Mutagenicity to mammalian cells of epoxides and other derivatives of polycyclic hydrocarbons. Proc. nat. Acad. Sci. (Wash.) 68, 3195–3199 (1971).CrossRefGoogle Scholar
  283. Huberman, E., Donovan, P. J., Dipaolo, J. A.: Mutation and transformation of cultured mammalian cells by N-acetoxy-N-fluorenylacetamide. J. nat. Cancer. Inst. 48, 837–840 (1972a).PubMedGoogle Scholar
  284. Huberman, E., Kuroki, T., Marquardt, H., Selkirk, J.K., Heidelberger, C., Grover, P.L., Sims, P.: Transformation of hamster embryo cells by epoxides and other derivatives of polycyclic hydrocarbons. Cancer Res. 32, 1391–1396 (1972b).PubMedGoogle Scholar
  285. Hueper, W.C., Conway, W.D.: Chemical carcinogenesis and cancers. Springfield, 111., U.S.A.: Charles C. Thomas 1964.Google Scholar
  286. Huggins, C., Grand, L., Fukunishi, R.: Aromatic influences on the yields of mammary cancers following administration of 7,12-dimethylbenz(a)anthracene. Proc. nat. Acad. Sci. (Wash.) 51, 737–742 (1964).CrossRefGoogle Scholar
  287. Huggins, C. B., Pataki, J., Harvey, R.G.: Geometry of carcinogenic polycyclic aromatic hydrocarbons. Proc. nat. Acad. Sci. (Wash.) 58, 2253–2260 (1967).CrossRefGoogle Scholar
  288. Huggins, C, Yang, N.C.: Induction and extinction of mammary cancer. Science 137, 257–262 (1962).PubMedCrossRefGoogle Scholar
  289. Ikegami, S., Nemoto, N., Sato, S., Sugimura, T.: Binding of 14C-labelled 4-nitroquinoline 1-oxide to DNA in vivo. Chem. Biol. Interactions 1, 321–330 (1969/1970).CrossRefGoogle Scholar
  290. Ingram, A.J.: The lethal and hepatocarcinogenic effects of dimethylnitrosamine injection in the newt, Triturus helveticus. Brit. J. Cancer 26, 206–215 (1972).PubMedCrossRefGoogle Scholar
  291. Inomata, M., Nagata, C.: Photoinduced phenoxyradical of 3,4-benzopyrene. Gann 63, 119–130 (1972).PubMedGoogle Scholar
  292. International Agency for Research on Cancer: I ARC monographs on the evaluation of carcinogenic risk of chemicals to man, vol. 2. Some inorganic and organometallic compounds. 1973.Google Scholar
  293. Irving, C. C.: Conjugates of TV-hydroxy compounds. IN: W. H. FISHMAN (ed.), Metabolic conjugation and metabolic hydrolysis, vol. 1, p. 53 119. New York: Academic Press, Inc. 1970.Google Scholar
  294. Irving, C.C.: Metabolic activation of N-hydroxy compounds by ionization. Xenobiotica 1, 387–398 (1971).PubMedCrossRefGoogle Scholar
  295. Irving, C.C., Janss, D.H., Russell, L.T.: Lack of N-hydroxy-2-acetylaminofluorene sulfotransferase activity in the mammary gland and Zymbal’s gland of the rat. Cancer Res. 31, 387–391 (1971).PubMedGoogle Scholar
  296. Irving, C. C., Veazey, R. A.: Differences in the binding of 2-acetylaminofluorene and its N-Hydroxy metabolite to liver nucleic acids of male and female rats. Cancer Res. 31, 19–22 (1971).PubMedGoogle Scholar
  297. Irving, C.C., Veazey, R.A., Russell, L.T.: Possible role of the glucuronide conjugate in the biochemical mechanism of binding of the carcinogen N-hydroxy-acetylaminofluorene to rat liver deoxyribonucleic acid in vivo. Chem-Biol. Interactions 1, 19–26 (1969/1970).Google Scholar
  298. Irving, C.C., Wiseman, R. JR.: Metabolism of the glucuronide of N-hydroxy-2-acetylaminofluorene in the rat. Cancer Res. 29, 812–816 (1969).PubMedGoogle Scholar
  299. Irving, C.C., Wiseman, R.: Studies on the carcinogenicity of the glucuronides of N-hydroxy-2- acetylaminofluorene and N-2-fluorenylhydroxylamine in the rat. Cancer Res. 31,1645–1648 (1971).PubMedGoogle Scholar
  300. Irving, C.C., Wiseman, R., JR., HILL, J.T.: Biliary excretion of the O-glucuronide of N-hydroxy-2- acetylaminofluorene by the rat and rabbit. Cancer Res. 27, 2309–2317 (1967a).PubMedGoogle Scholar
  301. Irving, C.C., Wiseman, R., JR., YOUNG, J.M.: Carcinogenicity of 2-acetylaminofluorene and N- hydroxy-2-acetylaminofluorene in the rabbit. Cancer Res. 27, 838–848 (1967b).PubMedGoogle Scholar
  302. Ishizawa, M., Endo, H.: Suppressor mutations induced by 4-nitroquinoline 1-oxide and 4-hydroxy- aminoquinoline 1-oxide in E. coli. Gann 63, 511–515 (1972).Google Scholar
  303. Ivankovic, S., Druckrey, H.: Transplazentare Erzeugung maligner Tumoren des Nervensystems. I. Äthylnitrosoharnstoff (ÄNH) an BD IX-Ratten. Z. Krebsforsch. 71, 320–360 (1968).PubMedCrossRefGoogle Scholar
  304. Ivankovic, S., Wohlenberg, H., Mennel, H.D., Preussmann, R.: Erzeugung von Herztumoren durch chronische orale Gabe des Carcinogens l-Pyridyl-3,3-Diäthyl-Triazen an BD Ratten. Z. Krebsforsch. 77, 217–225 (1972a).CrossRefGoogle Scholar
  305. Ivankovic, S., Zeller, W. J., SCHMÄHl, D.: Steigerung der carcinogenen Wirkung von Äthyl-nitroso- harnstoff durch Schwermetalle. Naturwissenschaften 59, 369 (1972b).PubMedCrossRefGoogle Scholar
  306. Iyer, V.N., Szybalski, W.: Mitomycins and porphyromycin: chemical mechanism of activation and cross linking of DNA. Science 145, 55–58 (1964).PubMedCrossRefGoogle Scholar
  307. Jackson, C.D., Irving, C.C.: The binding of N-hydroxy-2-acetylaminofluorene to replicating and non-replicating DNA in rat liver. Chem.-Biol. Interactions 2, 261–265 (1970).Google Scholar
  308. Jackson, C.D., Irving, C.C.: Effect of N-hydroxy-2-acetylaminofluorene on RNA and DNA synthesis. Biochem. Pharmacol. 22, 1247–1249 (1973).PubMedCrossRefGoogle Scholar
  309. Jänisch, W., Schreiber, D.: Experimentelle Geschwülste des Zentralnervensystems. Induktion, Mor-phologie, Transplantation und Anwendung. Jena: Fischer 1969.Google Scholar
  310. Jago, M. V.: The development of the hepatic megalocytosis of chronic pyrrolizidine alkaloid poisoning. Amer. J. Path. 56, 405–422 (1969).PubMedGoogle Scholar
  311. Jago, M.V., Edgar, J.A., Smith, L.W., Culvenor, C.C.J.: Metabolic conversion of heliotridine- based pyrrolizidine alkaloids to dehydroheliotridine. Molec. Pharmacol. 6, 402–406 (1970).Google Scholar
  312. Jago, M.V., Lanigan, G.W., Bingley, J.B., Piercy, D.W.T., Whittem, J.H., Titchen, D.A.: Excretion of the pyrrolizidine alkaloid heliotrine in the urine and bile of sheep. J. Path. 98, 115–128 (1969).PubMedCrossRefGoogle Scholar
  313. Janss, D. H., Moon, R. C, Irving, C. C.: The binding of 7,12-dimethylbenz(a)anthracene to mammary parenchyma DNA and protein in vivo. Cancer Res. 32, 254–258 (1972).PubMedGoogle Scholar
  314. Jaquier, A., Daudel, P.: Sur L’interaction in vivo du benzo-3,4-pyrene et de L’acide desoxyribonucle- ique de la peau de souris. C. R. Acad. Sci. Paris 258, 5775 (1964).Google Scholar
  315. Jerina, D.M., Daly, W., Witkop, B.: Role of arene oxide-oxepin systems in the metabolism of foreign substrates. II. Synthesis of 3,4-toluene-4–2H-oxide and subsequent “NIH sifts” to 4-hydroxytoluene-3–2H. J. Amer. chem. Soc. 90, 6523–6525 (1968).CrossRefGoogle Scholar
  316. Jerina, D.M., Daly, J.W., Witkop, B., ZALTZMAN-Nirenberg, P., Udenfriend, S.: Role of the arene oxide-oxepin system in the metabolism of aromatic substances. I. in vitro conversion of benzene oxide to a premercapturic acid and dihydrodiol. Arch. Biochem. Biophys. 128, 176–183 (1968a).CrossRefGoogle Scholar
  317. Jerina, D.M., Daly, J.W., Witkop, B., ZALTZMAN-Nirenberg, P., Udenfriend, S.: Role of the arene oxide-oxepin system in the metabolism of aromatic substrates. III. Formation of 1,2 naphthalene oxide from naphthalene by liver microsomes. J. Amer. chem. Soc. 90, 6525–6527 (1968b).CrossRefGoogle Scholar
  318. Jerina, D.M., Daly, J.W., Witkop, B., ZALTZMAN-Nirenberg, P., Udenfriend, S.: 1,2-naphthalene oxide as an intermediate in the microsomal hydroxylation of naphthalene. Biochemistry 9, 147–155 (1970).PubMedCrossRefGoogle Scholar
  319. Jones, K.W.: Chromosomal and nuclear localisation of mouse sattelite DNA in individual cells. Nature (Lond.) 225, 912–951 (1970).CrossRefGoogle Scholar
  320. Jungmann, R.A., Schweppe, J.S.: Binding of chemical carcinogens to nuclear proteins of rat liver. Cancer Res. 32, 952–959 (1972).PubMedGoogle Scholar
  321. Kasperek, G.J., Bruice, T.C.: The mechanism of aromatisation of arene oxides. J. Amer. chem. Soc. 94, 198–202 (1972).CrossRefGoogle Scholar
  322. Kasperek, G.J., Bruice, T.C., Yagi, H., Jerina, D.M.: Differentiation between the concerted and stepwise mechanisms for aromatisation (NIH shift) of arene epoxides. J. chem. Soc. Chem. Commun. 784, 115–179(1972).Google Scholar
  323. Katsuta, H., Takaoka, T.: A malignant transformation of rat liver parenchymal cells treated with 4-nitroquinoline 1-oxide in tissue culture. J. nat. Cancer Inst. 49, 1563–1576 (1972).PubMedGoogle Scholar
  324. Kawaji, K., Fukunishi, R., Terachi, S., Higashi, J., Watanabe, K.: Induction of mammary cancer in rats with cycasin: a preliminary report. Gann 59, 361 (1968).PubMedGoogle Scholar
  325. Kawazoe, Y., Huang, G., Araki, M, Koga, C.: Chemical binding of carcinogenic 4-nitroquinoline 1-oxide derivatives with DNA in vivo and in vitro. Gann 63, 161–166 (1972).PubMedGoogle Scholar
  326. Ketterer, B., Beale, D., Hackney, J.F.: The conjugation of aminoazo dye metabolites with a tripeptide and specific soluble proteins of the liver soluble cytoplasm of the rat. Xenobiotica 1, 551–552 (1971).PubMedCrossRefGoogle Scholar
  327. Ketterer, B., Christodoulides, L.: TWO specific azodye-carcinogen-binding proteins of the rat liver. The identity of amino acid residues which bind the azodye. Chem.-Biol. Interactions 1, 173–183 (1969).Google Scholar
  328. Ketterer, B., ROSS-Mansell, P., Whitehead, J.K.: The isolation of carcinogen-binding protein from livers of rats given 4-dimethylaminoazobenzene. Biochem. J. 103, 316–324 (1967).PubMedGoogle Scholar
  329. Keysell, G.R., Booth, J., Sims, P., Grover, P.L., Hewer, A.: The formation of an epoxide in the microsomal metabolism of 7,12-dimethylbenz(a)anthracene. Biochem. J. 129, 41p-42p (1972).PubMedGoogle Scholar
  330. Khan, A.U., Kasha, M.: An optical-residue singlet-oxygen theory of photocarcinogenicity. Ann. N. Y. Acad. Sci. 171, 24–33 (1970).CrossRefGoogle Scholar
  331. Kiese, M.: The biochemical production of ferrihemoglobin-forming derivatives from aromatic amines and mechanisms of ferrihemoglobin formation. Pharmacol. Rev. 18, 1091–1161 (1966).PubMedGoogle Scholar
  332. King, A.M.Q., Nicholson, B.H.: The interaction of aflatoxin Bi with polynucleotides and its effects on ribonucleic acid polymerase. Biochem. J. 114, 679–687 (1969).PubMedGoogle Scholar
  333. King, C.M., Olive, C.W.: Comparative effects of age, strain and species on the activation of N-hydroxy-2-fluorenylacetamide by soluble acyl transferases. Proc. Amer. Ass. Cancer Res. 14, 167 (1973).Google Scholar
  334. King, C.M., Phillips, B.: Enzyme-catalysed reactions of the carcinogen TV-hydroxy-2-fluorenylacet- amide with nucleic acid. Science 159, 1351–1353 (1968).PubMedCrossRefGoogle Scholar
  335. King, C.M., Phillips, B.: N-hydroxy-2-fluorenylacetamide: Reaction with guanosine, RNA, DNA and protein following enzymatic deacetylation or esterification. J. biol. Chem. 244, 6209–6216 (1969).PubMedGoogle Scholar
  336. King, C.M., Phillips, B.: Mechanism of introduction of fluorenylamide substituents into nucleic acid by rat liver. Proc. Amer. Ass. Cancer Res. 13, 43 (1972).Google Scholar
  337. Kinoshita, N., Gelboin, H.V.: The role of aryl hydrocarbon hydroxylase in 7,12-dimethylbenz- (a)anthracene skin tumorigenesis: on the mechanism of 7,8-benzoflavone inhibition of tumori- genesis. Cancer Res. 32, 1329–1339 (1972a).PubMedGoogle Scholar
  338. Kinoshita, N., Gelboin, H.V.: Aryl hydrocarbon hydroxylase and polycyclic hydrocarbon tumorigenesis. Effect of the enzyme inhibitor 7,8-benzoflavone on tumorigenesis and macromolecule binding. Proc. nat. Acad. Sci. (Wash.) 69, 824–828 (1972b).CrossRefGoogle Scholar
  339. Kinoshita, N., Shears, B., Gelboin, H.V.: K-region and non-K-region metabolism of benzo(a)pyrene by rat liver microsomes. Cancer Res. 33, 1937–1944 (1973).PubMedGoogle Scholar
  340. Kit, S.: Equilibrium sedimentation in density gradients of DNA preparations from animal tissues. J. molec. Biol. 3, 711–716(1961).PubMedCrossRefGoogle Scholar
  341. Kleihues, P.: Blockierung der DNS-Synthese durch N-methyl-N-nitrosoharnstoff in vivo. Arzneimit- tel-Forsch. 19, 1041–1043 (1969).Google Scholar
  342. Kleihues, P., Magee, P.N.: Alkylation of rat brain nucleic acids by N-methyl-N-nitrosourea and methyl methanesulphonate. J. Neurochem. 20, 595–606 (1973).PubMedCrossRefGoogle Scholar
  343. Kleihues, P., Magee, P.N., Austocker, J., Cox, D., Mathias, A.P.: Reaction of N-methyl-N- nitrosourea with DNA of neuronal and glial cells in vivo. FEBS Letters 32, 105–108 (1973).PubMedCrossRefGoogle Scholar
  344. Kleihues, P., Mende, C., Reucher, W.: Tumours of the peripheral and central nervous system induced in BD-rats by prenatal application of methyl methane sulphonate. Europ. J. Cancer 8, 641–645 (1972).CrossRefGoogle Scholar
  345. Kleihues, P., Patzschke, K.: Verteilung von N-[14C]methyl-N-nitrosoharnstoff in der Ratte nach systemischer Applikation. Z. Krebsforsch. 75, 193–200 (1971).PubMedCrossRefGoogle Scholar
  346. Klein, G.: Tumour specific transplantation antigens. G. H. A. Clowes memorial lecture. Cancer Res. 28, 625–635 (1968).PubMedGoogle Scholar
  347. Knecht, M.: Verteilung und Verweilzeit von Dimethylnitrosoamin im Organismus der Ratte. Z. Krebsforsch. 69, 293–296 (1967).PubMedCrossRefGoogle Scholar
  348. Kobayashi, A., Matsumoto, H.: Studies on methylazoxymethanol, the aglycone of cycasin. Isolation, biological and chemical properties. Arch. Biochem. 110, 373–380 (1965).PubMedCrossRefGoogle Scholar
  349. Kotin, P., Falk, H.L., Miller, A.: Effect of carbon tetrachloride intoxication on metabolism of benzo(a)pyrene in rats and mice. J. nat. Cancer Inst. 28, 725–745 (1962).Google Scholar
  350. Kriek, E.: On the mechanism of action of carcinogenic aromatic amines. I. Binding of 2- acetylaminofluorene and N-hydroxy-2-acetylaminofluorene to rat liver nucleic acids in vivo. Chem.-Biol. Interactions 1, 3–17 (1969).CrossRefGoogle Scholar
  351. Kriek, E.: On the mechanism of action of carcinogenic aromatic amines. II. Binding of N-hydroxy-N- acetyl-4-aminobiphenyl to rat-liver nucleic acids in vivo. Chem.-Biol. Interactions 3, 19–28 (1971).Google Scholar
  352. Kriek, E.: Persistent binding of a new reaction product of the carcinogen Ar-hydroxy-Ar-2-acetyl- aminofluorene with guanine in rat liver DNA in vivo. Cancer Res. 32, 2042–2048 (1972).PubMedGoogle Scholar
  353. Kriek, E., MILLER, J. A., Juhl, U., MILLER, E.C.: 8-(Ar-2-Fluorenylacetamide)guanosine, an arylami- dation reaction product of guanosine and the carcinogen A-acetoxy-A-2-fluorenylacetamide in neutral solution. Biochemistry 6, 177–182 (1967).PubMedCrossRefGoogle Scholar
  354. Kriek, E., Reitsema, J.: Interaction of the carcinogen Af-acetoxy-N-2-acetylaminofluorene with poly- adenylic acid: dependence of reactivity on conformation. Chem.-Biol. Interactions 3, 397–400 (1971).Google Scholar
  355. KRÜGer, F.W.: Metabolismus von Nitrosaminen in vivo. 1. Über die -Oxydation aliphatischer Di-n-alkylnitrosamin. Die Bildung von 7-Methylguanin neben 7-Propyl- bzw. 7-Butylguanin nach Applikation von Di-n-propyl- oder Di-n-butylnitrosamin. Z. Krebsforsch. 76, 145–154 (1971).CrossRefGoogle Scholar
  356. Krüger, F.W.: New aspects in metabolism of carcinogenic nitrosamines. IN: Topics in chemical carcinogenesis (Nakahara, W., Takayama, S., Sugimura, T., Odashima, S., eds.), p. 213–235. Tokyo: University of Tokyo Press 1972.Google Scholar
  357. Krüger, F.W., Preussman, R., Niepelt, N.: Mechnism of carcinogenesis with l-aryl-3,3-dialkyltria- zenes. III. In vivo methylation of RNA and DNA with l-phenyl-3,3-[14C]-dimethyltriazene. Biochem. Pharmacol. 20, 529–533 (1971).PubMedCrossRefGoogle Scholar
  358. Krüger, F. W., Wiessler, M., RÜCker, U.: Investigation of the alkylating action of 1,1-dimethylhyd- razine. Biochem. Pharmacol. 19, 1825 (1970).PubMedCrossRefGoogle Scholar
  359. Kuroki, T., Heidelberger, C.: Determination of “h” protein in transformable and transformed cells in culture. Biochemistry 11, 2116–2124 (1972).PubMedCrossRefGoogle Scholar
  360. Kuroki, T., Huberman, E., Marquardt, H., Selkirk, J.K., Heidelberger, C., Grover, P.L., Sims, P.: Binding of k-region epoxides and other derivatives of benz(a)anthracene and dibenz(a,h)- anthracene to DNA, RNA and protein of transformable cells. Chem.-Biol. Interactions 4, 389–391 (1971/72).Google Scholar
  361. Lacassagne, A., Zajdela, F., Buu-hoÏ, N.P., Chalvet, H.: Sur l’activité cancérogenè du 3,4–9,10-dibenzopyrènz et de quelques-uns de ses derivatives. C. R. Acad. Sci. (Paris) 244, 273–274 (1957a).Google Scholar
  362. Lacassagne, A., Buu-Hoï, N.P., Zajdela, F.: Sur l’activité cancérogène de dérivés méthylés du pérylène et du 1.12-benzopérylène. C. R. Acad. Sci. (Paris) 245, 991–994 (1957b).Google Scholar
  363. Lacassagne, A., Buu-Hoï, N.P., Zajdela, F.: Absence de propriété sarcomogène chez le dibenzo(a,c)- anthracene: nette activité de son dérivé 10-méthylé. Europ. J. Cancer 4, 123–127 (1968).CrossRefGoogle Scholar
  364. Lafarge, C., Frayssinet, C., Derecondo, A.M.: Inhibition par l’aflatoxine de la synthèse de RNA hépatique chez le rat. Bull. Soc. Chim. biol. (Paris) 47, 1724–1725 (1965).Google Scholar
  365. Lancet. (No author) Leading Article: nitrites, nitrosamines and cancer. Lancet 19681, 1071–1072.Google Scholar
  366. Lanigan, G.W., Smith, L.W.: The metabolism of pyrrolizidine alkaloids in the ovine rumen. Part. 1. The formation of 7a-hydroxy-la-methyl-8a-pyrrolizidine from heliotrine and lasiocarpine. Aust. J. Agric. Res. 21, 493–500 (1970).CrossRefGoogle Scholar
  367. Laqueur, G.L.: Carcinogenic effects of cycad meal and cycasin, methylazoxymethanol glycoside, in rats and effects of cycasin in germfree rats. Fed. Proc. 23, 1386–1387 (1964).PubMedGoogle Scholar
  368. Laqueur, G.L.: The induction of intestinal neoplasm in rats with the glycoside cycasin and its aglycone. Virchows Arch. path. Anat. 340, 151–163 (1965).Google Scholar
  369. Laqueur, G.L.: Toxicology of cycasin. Fd. Cosmet. Toxicol. 6, 565–589 (1968).CrossRefGoogle Scholar
  370. Laqueur, G.L., Mcdaniel, E.G., Matsumoto, H.: Tumor induction in germfree rats with methyl- azoxymethanol (MAM) and synthetic MAM acetate. J. nat. Cancer Inst. 39, 355–371 (1967).PubMedGoogle Scholar
  371. Laqueur, G. L., Matsumoto, H.: Neoplasms in female Fischer rats following intraperitoneal injection of methylazoxymethanol. J. nat. Cancer Inst. 37, 217–232 (1966).PubMedGoogle Scholar
  372. Laqueur, G.L., Mickelsen, O., Whiting, M.G., Kurland, L.T.: Carcinogenic properties of nuts from Cycas Circinalis L, indigenous to Guam. J. nat. Cancer Inst. 31, 919–951 (1963).PubMedGoogle Scholar
  373. Laqueur, G. L., Spatz, M.: Toxicology of cycasin. Cancer Res. 28, 2262–2267 (1968).PubMedGoogle Scholar
  374. Laskin, S., Kuschner, M., Drew, R.T., Cappiello, P., Nelson, N.: Tumors of the respiratory tract induced by inhalation of bis(chloromethyl)ether. Arch, environ. Hlth. 23, 135–136 (1971).Google Scholar
  375. Lawley, P. D.: Effects of some chemical mutagens and carcinogens on nucleic acids. Progr. Nucleic Acid Res. and Mol. Biol. 5, 89–131 (1966).CrossRefGoogle Scholar
  376. Lawley, P.D.: The action of alkylating mutagens and carcinogens on nucleic acids: N-methyl-N- nitroso compounds as methylating agents. In: Topics in Chemical Carcinogenesis (Nakahara, W., Takayama, S., Sugimura, T., Odeshuma, S., eds.), p. 237–256. Tokyo: University of Tokyo Press 1972.Google Scholar
  377. Lawley, P. D., Wallick, C. A.: The action of alkylating agents on deoxyribonucleic acid and guanylic acid. Chem. and Ind., p. 633 (1957).Google Scholar
  378. Leaver, D.D., Swann, P.F., Magee, P.N.: Induction of tumours in the rat by a single oral dose of N-nitrosomethylurea. Brit. J. Cancer 23, 177–187 (1969).PubMedCrossRefGoogle Scholar
  379. Lee, K.Y., Lijinsky, W.: Alkylation of rat liver RNA by cyclic N-nitrosamines in vivo. J. nat. Cancer Inst. 37, 401–406 (1966).PubMedGoogle Scholar
  380. Legator, M.S.: Biological effects of aflatoxin in cell cultures. Bact. Rev. 30, 471–477 (1966).PubMedGoogle Scholar
  381. Lesko, S.A., Hoffman, H.D., Ts’O, P.O.P., Maher, V.M.: Interaction and linkage of polycyclic hydrocarbons to nucleic acids. Progr. in Mol. and Subcell. Biol. 2, 347–370 (1971).Google Scholar
  382. Lesko, S.A., Ts’O, P.O.P., Umans, R.S.: Interaction of nucleic acids. V. Chemical linkage of 3,4- benzpyrene to deoxyribonucleic acid in aqueous solution. Biochemistry 8, 2291–2298 (1969).PubMedCrossRefGoogle Scholar
  383. Lijinsky, W.: Aflatoxins and nitrosamines: cellular interactions and carcinogenesis. N. Z. med. J. 67, 100–109 (1968).PubMedGoogle Scholar
  384. Lijinsky, W., Epstein, S.S.: Nitrosamines as environmental carcinogens. Nature (Lond.) 225, 21–23 (1970).CrossRefGoogle Scholar
  385. Lijinsky, W., Garcia, H., Saffiotti, U.: Structure-activity relationships among some polynuclear hydrocarbons and their hydrogenated derivatives. J. nat. Cancer Inst. 44, 641–649 (1970a).PubMedGoogle Scholar
  386. Lijinsky, W., Lee, K.Y., Gallagher, C.H.: Interaction of aflatoxin and GI with tissues of the rat. Cancer Res. 30, 2280–2283 (1970b).PubMedGoogle Scholar
  387. Lijinsky, W., Loo, J., Ross, A. E.: Mechanism of alkylation of nucleic acids by nitrosodimethylamine. Nature (Lond.) 218, 1174–1175 (1968).CrossRefGoogle Scholar
  388. Lijinsky, W., Ross, A.E.: Alkylation of rat liver nucleic acids not related to carcinogenesis by N-nitrosamines. J. nat. Cancer Inst. 42, 1095–1100 (1969).PubMedGoogle Scholar
  389. Lillehoj, E.B., Ciegler, A.: A biological activity of aflatoxin B2a- Appl. Microbiol. 17, 516–519 (1969).Google Scholar
  390. Lin, J.-K., Miller, J. A., Miller, E.C.: Studies on structure of polar dyes derived from the liver proteins of rats fed jV-methyl-4-aminoazobenzene. II. Identity of synthetic 3-(homocystein-S-yl)-7V- methyl-4-aminoazobenzene with the major polar dye P2b. Biochemistry 7, 1889–1895 (1968).PubMedCrossRefGoogle Scholar
  391. Lin, J.-K., Miller, J. A., Miller, E.C.: Studies on structures of polar dyes derived from the liver proteins of rats fed 7V-methyl-4-aminoazobenzene. III. Tyrosine and homocysteine sulfoxide polar dyes. Biochemistry 8, 1573–1582 (1969).PubMedCrossRefGoogle Scholar
  392. Lingens, F., Haerlin, R., Sussmutii, R.: Mechanism of mutagenesis by N-methyl-N’-nitro-N-nitroso- guanidine (MNNG). Methylation of nucleic acids by N-trideuteriomethyl-N’-nitro-N-nitroso- guanidine (D3-MNNG) in the presence of cysteine and in cells of Escherichia coli. FEBS Letters 13, 241–242 (1971).PubMedCrossRefGoogle Scholar
  393. Liquori, A.M., Delerma, B., Ascoli, F., Botre, C., Trasciatti, M.: Interaction between DNA and polycyclic hydrocarbons. J. molec. Biol. 5, 521–526 (1962).CrossRefGoogle Scholar
  394. Litwack, G., Ketterer, B. ARIAS, I. M.: Ligandin: a hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions. Nature (Lond.) 234, 466–467 (1971).CrossRefGoogle Scholar
  395. Lorenz, E., Stewart, H.L.: Tumours of the alimentary tract induced in mice by feeding olive oil emulsions containing carcinogenic hydrocarbons. J. nat. Cancer Inst. 7, 227–238 (1947).PubMedGoogle Scholar
  396. Lotlikar, P.D.: Effects of sex hormones on enzymic esterification of 2-(N-hydroxyacetamido)fluorene by rat liver cytosol. Biochem. J. 120, 409–416 (1970).PubMedGoogle Scholar
  397. Lotlikar, P.D., Luha, L.: Acylation of carcinogenic hydroxamic acids by carbamoyl phosphate to form reactive esters. Biochem. J. 124, 69–74 (1971).PubMedGoogle Scholar
  398. Lotlikar, P.D., Paik, W.K.: Binding of carcinogenic aromatic amines to rat liver nuclear acidic proteins in vivo. Biochem. J. 124, 443–445 (1971).PubMedGoogle Scholar
  399. Lotlikar, P.D., Scribner, J.D., Miller, J. A., Miller, E.C.: Reactions of esters of aromatic -hydroxy amines and amides with methionine in vitro: a model for in vivo binding of amine carcinogens to proteins. Life Sci. 5, 1263–1269 (1966).CrossRefGoogle Scholar
  400. Lotlikar, P.D., Wasserman, M.B.: Reactive phosphate ester of the carcinogen 2-(N-hydroxy)- acetamidofluorene. Biochem. J. 120, 661–665 (1970).PubMedGoogle Scholar
  401. Loveless, A.: Genetic and allied effects of alkylating agents. London: Butterworths 1966.Google Scholar
  402. Loveless, A.: Possible relevance of 0–6 alkylation of deoxyguanosine to the mutagenicity and carcino-genicity of nitrosamines and nitrosamides. Nature (Lond.) 223, 206–207 (1969).CrossRefGoogle Scholar
  403. Ludlum, D. B.: The properties of 7-methylguanine-containing templates for ribonucleic acid polymerase. J. biol. Chem. 245, 477–482 (1970a).PubMedGoogle Scholar
  404. Ludlum, D.B.: Alkylated polycytidylic acid templates for RNA polymerase. Biochim. biophys. Acta (Amst.) 213, 142–148 (1970b).Google Scholar
  405. Ludlum, D.B., Magee, P.N.: Reaction of nitrosoureas with polycytidylate templates for ribonucleic acid polymerase. Biochem. J. 128, 729–731 (1972).PubMedGoogle Scholar
  406. Ludlum, D. B., Wilhelm, R. C.: Ribonucleic acid polymerase reactions with methylated polycytidylic acid templates. J. biol. Chem. 243, 2750–2753 (1968).PubMedGoogle Scholar
  407. Mccalla, D. R.: Reaction of N-methyl-N’-nitro-N-nitroguanidine (sic) and N-methyl-N-nitroso-p- toluenesulphonamide with DNA in vitro. Biochim. biophys. Acta (Amst.) 155, 114–120 (1968).Google Scholar
  408. Mclean, E. K.: The toxic actions of pyrrolidine (senecio) alkaloids. Pharmacol. Revs. 22, 429–483 (1970).Google Scholar
  409. Mclean, A.E.M., Day, P.: The use of new methods to measure the effect of diet and inducers of microsomal enzyme synthesis on cytochrome P450 in liver homogenates and on metabolism of dimethylnitrosamine. Biochem. Pharmacol. 23, 1173–1180 (1974).PubMedCrossRefGoogle Scholar
  410. Mclean, A.E.M., Mclean, E.: Diet and toxicity. Brit. med. Bull. 25, 278–281 (1969).Google Scholar
  411. Mclean, A.E.M., Magee, P.N.: Increased renal carcinogenesis by dimethylnitrosamine in protein- deficient rats. Brit. J. exp. Path. 51, 587–590 (1970).PubMedGoogle Scholar
  412. Mclean, A. E. M., Marshall, A.: Reduced carcinogenic effects of aflatoxin in rats given phenobarbi- tone. Brit. J. exp. Path. 52, 322–329 (1971).Google Scholar
  413. Mclean, A.E.M., Verschuuren, H.G.: Effects of diet and microsomal enzyme induction on the toxicity of dimethylnitrosamine. Brit. J. exp. Path. 50, 22–25 (1969).PubMedGoogle Scholar
  414. Mclean, A.E.M., Witschi, H.P.: The effect of protein depletion on toxic liver injury produced by chloroform, dimethylnitrosamine and beryllium. Biochem. J. 100, 11P-12P (1966).Google Scholar
  415. Mcmahon, R.E., Sullivan, H.R., Craig, J.C., Pereira, W.E.: The microsomal oxygenation of ethyl benzene: isotopic, stereochemical, and induction studies. Arch. Biochem. Biophys. 132, 575–576 (1969).PubMedCrossRefGoogle Scholar
  416. Magee, P.N.: Toxic liver injury. The metabolism of dimethylnitrosamine. Biochem. J. 64, 676–682 (1956).PubMedGoogle Scholar
  417. Magee, P.N.: The possible significance of alkylation in carcinogenesis. N. Z. med. J. 67, 59–72 (1968).PubMedGoogle Scholar
  418. Magee, P.N.: In vivo reactions of nitroso compounds. Ann. N. Y. Acad. Sci. 163, 717–730 (1969).CrossRefGoogle Scholar
  419. Magee, P. N.: The possible role of nucleic acid methylases in the induction of cancer. Cancer Res. 31,599–604(1971).PubMedGoogle Scholar
  420. Magee, P.N.: Possible mechanisms of carcinogenesis and mutagenesis by nitrosamines. In: Topics in chemical carcinogenesis (Nakahara, W., Takayama, S., Sugimura, T., Odashima, O., eds.), p. 259–278. Tokyo: University of Tokyo Press 1972.Google Scholar
  421. Magee, P.N., Barnes, J.M.: The production of malignant primary hepatic tumours in the rat by feeding dimethylnitrosamine. Brit. J. Cancer 10, 114–122 (1956).PubMedCrossRefGoogle Scholar
  422. Magee, P.N., Barnes, J.M.: The experimental production of tumours in the rat by dimethylnitrosamine. Acta Un. int. Cancr. 15, 187–190 (1959).Google Scholar
  423. Magee, P.N., Barnes, J.M.: Induction of kidney tumours in the rat with dimethylnitrosamine (N-nitrosodimethylamine). J. Path. Bact. 84, 19–31 (1962).PubMedCrossRefGoogle Scholar
  424. Magee, P.N., Barnes, J.M.: Carcinogenic nitroso compounds. Advanc. Cancer Res. 10, 163–246 (1967).CrossRefGoogle Scholar
  425. Magee, P.N., FÄrber, E.: Toxic liver injury and carcinogenesis. Methylation of rat liver nucleic acids by dimethylnitrosamine in vivo. Biochem. J. 83, 114–124 (1962).PubMedGoogle Scholar
  426. Magee, P.N., Hawks, A., Stewart, B.W., Swann, P.F.: Mechanisms of carcinogenesis by alkyl- nitrosamine and related compounds. In: Pharmacology and the future of man. Proc. 5th Int. Congr. Pharmacology, San Francisco 1972, vol. 2, p. 140–149, Basel: Karger 1973.Google Scholar
  427. Magee, P.N., Hultin, T.: Toxic liver injury and carcinogenesis; methylation of proteins of rat-liver slices by dimethylnitrosamine in vitro. Biochem. J. 83, 106–114 (1962).PubMedGoogle Scholar
  428. Magee, P.N., Lee, K.Y.: Cellular injury and carcinogenesis. Alkylation of ribonucleic acid of rat liver by diethylnitrosamine and “-butylmethylnitrosamine in vivo. Biochem. J. 91, 35–112 (1964).PubMedGoogle Scholar
  429. Magee, P.N., Montesano, R., Preussmann, R.: N-nitroso compounds and related carcinogens. In: American Chemical Society Monograph on Chemical Carcinogenesis. In the press (1975).Google Scholar
  430. Magee, P.N., Schoental, R.: Carcinogenesis by nitroso compounds. Brit. med. Bull. 20, 102–106 (1964).PubMedGoogle Scholar
  431. Magee, P. N., Swann, P. F.: Nitroso compounds. Brit. med. Bull. 25, 240–244 (1969).PubMedGoogle Scholar
  432. Maher, V.M., Lesko, S.A., Straat, P.A., Ts’O, P.O.P.: Mutagenic action, loss of transforming activity, and inhibition of deoxyribonucleic acid template activity in vitro, caused by chemical linkage of carcinogenic polycyclic hydrocarbons to deoxyribonucleic acid. J. Bact. 108, 202–212 (1971).PubMedGoogle Scholar
  433. Mäher, V.M., Miller, E.C., Miller, J.A., Summers, W.C.: Mutations and loss of transforming activity of Bacillus subtilis DNA after reaction with esters of carcinogenic N-hydroxy aromatic amides. Cancer Res. 30, 1473–1480 (1970).PubMedGoogle Scholar
  434. MÄHer, V.M., Miller, E.C., Miller, J.A., Szybalski, W.: Mutations and decreases in density of transforming DNA produced by derivatives of the carcinogens 2-acetylaminofluorene and N-methyl-4aminoazobenzene. Molec. Pharmacol. 4, 411–426 (1968).Google Scholar
  435. Mainster, M.A., Memory, J.D.: Superdelocalisability indices and the Pullman theory of chemical carcinogenesis. Biochim. biophys. Acta (Amst.) 148, 605–608 (1967).CrossRefGoogle Scholar
  436. Malling, H. V,: Dimethylnitrosamine: formation of mutagenic compounds by interaction with mouse liver microsomes. Mutation Res. 13, 425–429 (1971).PubMedCrossRefGoogle Scholar
  437. Marquardt, H., Bendich, A., Philips, F.S., Hoffman, D.: Binding of [G-H3]-7,12-dimethyl- benz(a)anthracene to DNA of normal and rapidly dividing hepatic cells in rats. Chem.-Biol. Interactions 3, 1–11 (1971).Google Scholar
  438. Marquardt, H., Heidelberger, C: Influence of “feeder cells” and inducers and inhibitors of microsomal mixed function oxidases on hydrocarbon induced malignant transformation of cells derived from C3H mouse prostate. Cancer Res. 32, 721–725 (1972).PubMedGoogle Scholar
  439. Marquardt, H., Kuroki, T., Huberman, E., Selkirk, J.K., Heidelberger, C, Grover, P.L., Sims, P.: Malignant transformation of cells derived from mouse prostate by epoxides and other derivatives of polycyclic hydrocarbons. Cancer Res. 32, 716–720 (1972).PubMedGoogle Scholar
  440. MARQUARDT, H., SODERGREN, J.E., SIMS, P., GROVER, P.L.: Malignant transformation in vitro of mouse fibroblasts by 7,12-dimethylbenz(a)anthracene, 7-hydroxymethylbenz(a)anthracene and by their k-region derivatives. Proc. Amer. Ass. Cancer Res. Abstr. 27 (1973).Google Scholar
  441. Marquardt, H., Sternberg, S. S., Philips, F. S.: 7,12dimethylbenz(a)anthracene and hepatic neoplasia in regenerating rat liver. Chem.-Biol. Interactions 2, 401–403 (1970).CrossRefGoogle Scholar
  442. Matsumoto, H., Higa, H.H.: Studies onmethylazoxymethanol, theaglyconeofcycasin: methylation of nucleic acids in vitro. Biochem. J. 98, 20c-22c (1966).PubMedGoogle Scholar
  443. Matsumoto, H., Nagawama, T., Larson, H.O.: Studies on methylazoxymethanol, the aglycone of cycasin: a synthesis of methylazoxymethyl acetate. Biochem. J. 95, 13c-14c (1965).PubMedGoogle Scholar
  444. Matsumoto, H., Strong, F.M.: The occurence of methylazoxymethanol in Cycas circinalis L. Arch. Biochem. 101,299–310(1963).CrossRefGoogle Scholar
  445. Matsushima, T., Grantham, P.H., WEISBURGER, E.K., Weisburger, J.H.: Phenobarbital-mediated increase in ring and N-hydroxylation of the carcinogen N-2-fluorenylacetamide and decrease in amount bound to liver DNA. Biochem. Pharmacol. 21, 2047–2051 (1972).CrossRefGoogle Scholar
  446. Matsushima, T., Kobuna, I., Sugimura, T.: In vivo interaction of 4-nitroquinoline 1-oxide and its derivatives with DNA. Nature (Lond.) 216, 508 (1967).CrossRefGoogle Scholar
  447. Matsushima, T., Weisburger, J.H.: Effect of carbon monoxide or of 3-aminotriazole on C- and N-hydroxylation of the carcinogen N-2-fluorenylacetamide by liver microsomes of hamsters pre- treated with 3-methylcholanthrene. Xenobiotica 2, 423–430 (1972).PubMedCrossRefGoogle Scholar
  448. Mattocks, A.R.: Toxicity of pyrrolizidine alkaloids. Nature (Lond.) 217, 723–728 (1968).CrossRefGoogle Scholar
  449. Mattocks, A. R.: Synthetic compounds with toxic properties similar to those of pyrrolizidine alkaloids and their pyrrolic metabolites. Nature (Lond.) 232, 476–477 (1971).CrossRefGoogle Scholar
  450. Mattocks, A.R.: Toxicity and metabolism of senecio alkaloids. In: Phytochemical ecology, p. 179–200, ed. J.B. HARBORNE. New York and London: Academic Press 1972a.Google Scholar
  451. Mattocks, A.R.: Acute hepatotoxicity and pyrrolic metabolites in rats dosed with pyrrolizidine alkaloids. Chem.-Biol. Interactions 5, 227–242 (1972b).Google Scholar
  452. Mattocks, A.R., White, I.N.H.: The conversion of pyrrolizidine alkaloids to N-oxides and to dihydropyrrolizine derivatives by rat liver microsomes in vitro. Chem.-Biol. Interactions 3, 383–396 (1971a).Google Scholar
  453. Mattocks, A. R., White, I. N. H.: Pyrrolic metabolites from non-toxic pyrrolizidine alkaloids. Nature (Lond.) New Biol. 231, 114–115 (1971b).CrossRefGoogle Scholar
  454. Meuwissen, J.A.T.P., Ketterer, B., Mertens, B. B. E.: Haematin and bilirubin binding to Ligandin. Digestion 6, 293 (1972).Google Scholar
  455. Michelson, A.M., Pochon, F.: Effect of carcinogens on DNA. Action of 7-bromomethylbenz(a)an- thracene. Biochemie 54, 18–24 (1972).Google Scholar
  456. Miller, E.C.: Studies on the formation of protein bound derivatives of 3,-4-benzpyrene in the epidermal fraction of mouse skin. Cancer Res. 11, 100–108 (1951).PubMedGoogle Scholar
  457. Miller, E.C., Lotlikar, P.D., MILLER, J. A., Butler, B.W., Irving, C.C., Hill, J.T.: Reactions in vivo of some tissue nucleophiles with the glucuronide of A-hydroxy-2-acetylaminofluorene. Molec. Pharmacol. 4, 147–154 (1968).Google Scholar
  458. Miller, E.C., Lotlikar, P.D., Pitot, H.C., Fletcher, T.L., Miller, J.A.: N-hydroxy metabolites of 2-acetylaminophenanthrene and 7-fluoro-2-acetylaminofluorene as proximate carcinogens in the rat. Cancer Res. 26, 2239–2247 (1966).PubMedGoogle Scholar
  459. Miller, E.C., Miller, J.A.: Mechanisms of chemical carcinogenesis: Nature of proximate carcinogens and interactions with macromolecules. Pharmacol. Rev. 18, 805–838 (1966a).PubMedGoogle Scholar
  460. iller, E.C., iller, J. A.: Low carcinogenicity of the k-region epoxides of 7-methylbenz(a)anthra- cene in the mouse and rat. Proc. Soc. exp. Biol. (N.Y.) 124, 915–919 (1967a).Google Scholar
  461. Miller, E.C., Miller, J. A., Enomoto, M.: The comparative carcinogenicities of 2-acetylaminofluor- ene and its TV-hydroxy metabolite in mice, hamsters and guinea pigs. Cancer Res. 24, 2018–2032 (1964).PubMedGoogle Scholar
  462. iller, E.C., iller, J. A., Hartmann, H.A.: VV-hydroxy-2-acetylaminofluorene: a metabolite of acetylaminofluorene with increased carcinogenic activity in the rat. Cancer Res. 21, 815–824 (1961a).PubMedGoogle Scholar
  463. Miller, J.A.: Comments on chemistry of cycads. Fed. Proc. 23, 1361–1362 (1964).PubMedGoogle Scholar
  464. Miller, J. A.: Carcinogenesis by chemicals: an overview-G.H.A. Clowes Memorial Lecture. Cancer Res. 30, 559–576(1970).PubMedGoogle Scholar
  465. Miller, J. A., Miller E.C.: The carcinogenic aminoazo dyes. In: J.P. GREENSTEIN and A. HADDOW (eds.), Advanc. Cancer Res. 1, 339–396 (1953).Google Scholar
  466. Miller, J. A., iller, E.C.: A survey of molecular aspects of chemical carcinogenesis. Lab. Invest. 15, 217–239 (1966b).Google Scholar
  467. Miller, J. A., Miller, E.C.: Activation of carcinogenic aromatic amines and amides by TV-hydroxyl- ation. In: Carcinogenesis: a broad critique. University of Texas, M.D. Anderson Hospital and Tumour Institute at Houston, p. 397–420. Baltimore: The Williams and Wilkins Co. 1967b.Google Scholar
  468. Miller, J. A., Miller, E.C.: Metabolic activation of carcinogenic aromatic amines and amides via TV-hydroxylation and N-hydroxy-esterification and its relationship to ultimate carcinogens as electrophilic reactants. In: E.D. BERGMANN and B. PULLMAN (eds.), The Jerusalem Symposia on Quantum Chemistry and Biochemistry. Physicochemical mechanisms of carcinogenesis, vol. 1, p. 237–261. Jerusalem: Israel Academy of Sciences and Humanities 1969a.Google Scholar
  469. Miller, J. A., Miller, E.C.: The metabolic activation of carcinogenic aromatic amines and amides. Prog. exp. Tumor Res. 11, 273–301 (1969b).Google Scholar
  470. Miller, J. A., Wyatt, C. S., MILLER, E. C., Hartmann, H. A.: The 7V-hydroxylation of 4-acetylamino- biphenyl by the rat and dog and the strong carcinogenicity of 7V-hydroxy-4-acetyl-aminobiphenyl in the rat. Cancer Res. 21, 1465–1473 (1961b).Google Scholar
  471. Mohr, U., Althoff, J., Page, N.: Tumors of the respiratory system induced in the common European hamster by N-diethylnitrosamine. J. nat. Cancer Inst. 49, 595–597 (1972).PubMedGoogle Scholar
  472. MÖHr, U., Hilfrich, J.: Effect of a single dose of N-diethylnitrosamine on the rat kidney. J. nat. Cancer Inst. 49, 1729–1731 (1972).PubMedGoogle Scholar
  473. Mondal, S., Heidelberger, C.: in vitro malignant transformation by methylcholanthrene of the progeny of a single cell derived from C3H mouse prostate. Proc. nat. Acad. Sci. (Wash.) 65, 219–225 (1970).CrossRefGoogle Scholar
  474. Montesano, R., Magee, P.N.: Metabolism of dimethylnitrosamine by human liver slices in vitro. Nature (Lond.) 228, 173–174 (1970).CrossRefGoogle Scholar
  475. Montesano, R., Magee, P.N.: Metabolism of nitrosamines by rat and hamster tissue slices in vitro. Proc. Amer. Ass. Cancer Res. 12, 14 (1971).Google Scholar
  476. Montesano, R., MÖHr, U., Magee, P.N., Hilfrich, J., Haas, H.S.: Additive effect in the induction of kidney tumours in rats treated with dimethylnitrosamine and ethyl methanesulphonate. Brit. J. Cancer, 29, 50–58 (1974).PubMedCrossRefGoogle Scholar
  477. Morreal, C.E., Dao, T.L., Eskins, K., King, C.L., Dienstag, J.: Peroxide induced binding of hydrocarbons to DNA. Biochim. biophys. Acta (Amst.) 169, 224–229 (1968).Google Scholar
  478. Moule, Y.: Effects of aflatoxin Bj on the formation of subribosomal particles in rat liver. Cancer Res. 33, 514–520 (1973).PubMedGoogle Scholar
  479. Moule, Y., Frayssinet, C.: Effect of aflatoxin on transcription in liver cell. Nature (Lond.) 218, 93–95 (1968).CrossRefGoogle Scholar
  480. Moule, Y., Frayssinet, C.: Action de deux hépatocarcinogénes sur l’activité RNA-polymerase des noyaux isolés du foie. Bull. Soc. Chim. biol. (Paris) 51, 1544 (1969).Google Scholar
  481. Murphy, G. P., Mirand, E.A., Johnston, G. S., Schmidt, T.D., Scott, W.W.: Renal tumours induced by a single dose of dimethylnitrosamine: morphologic, functional, enzymatic and hormonal characterisations. Invest. Urology 4, 39–56 (1966).Google Scholar
  482. Nagata, C., Imamura, A.: Electronic structures and mechanism of carcinogenicity for alkylnitros- amines. Gann 61, 169–176 (1970).PubMedGoogle Scholar
  483. Nagata, C., Kodama, M., Tagashira, Y.L.: Electron spin resonance study on the interaction between chemical carcinogens and tissue components. II. Free radical produced by stirring aromatic hydrocarbons with tissue components such as skin homogenates or proteins. Gann 58, 493–504 (1967).PubMedGoogle Scholar
  484. Nagata, C., Tagashira, Y., Inomata, M., Kodama, M.: Effect of iodine on the carcinogenicity of 3,4-benzopyrene. Gann 62, 309–314 (1971a).PubMedGoogle Scholar
  485. Nagata, C., Tagashira, Y., Inomata, M., Kodama, M.: Carcinogenic activity of 5-hydroxy-3,4- benzopyrene. Gann 62, 419–421 (1971b).PubMedGoogle Scholar
  486. Nagata, Y., Matsumoto, H.: Studies on methylazoxymethanol: methylation of nucleic acids in the fetal rat brain. Proc. Soc. exp. Biol. (N. Y.) 132, 383–385 (1969).Google Scholar
  487. Nakahara, W., Fukuoka, F., Sugimura, T.: Carcinogenic action of 4-nitroquinoline 1-oxide. Gann 48, 129–137 (1957).Google Scholar
  488. Nakahara, W., Takayama, S., Sugimura, T., Odashima, S. (eds.): Topics in chemical carcinogenesis. Tokyo: University of Tokyo Press 1972.Google Scholar
  489. Nakashima, S., Ono, S.: Immune suppression induced by 4-nitroquinoline 1-oxide and its derivatives. Gann 63, 111–117 (1972).PubMedGoogle Scholar
  490. Natori, Y.: Studies on ethionine. VI. Sex-dependent behaviour of methionine and ethionine in rats. J. biol. Chem. 238, 2075–2080 (1963).PubMedGoogle Scholar
  491. Neal, G.E.: The effect of aflatoxin B! on normal and cortisol-stimulated rat liver RNA synthesis. Biochem. J. 130, 619–629 (1972).PubMedGoogle Scholar
  492. Nebert, D. W., Benedict, W. F., Gielen, J. E., Oesch, F., Daly, J. W.: Aryl hydrocarbon hydroxylase, epoxide hydrase and 7,12-dimethylbenz(a)anthracene-produced skin tumorigenesis in the mouse. Molec. Pharmacol. 8, 374–379 (1972).Google Scholar
  493. Nebert, D.W., Gelboin, H.V.: The in vivo and in vitro induction of aryl hydrocarbon hydroxylase in mammalian cells of different species, tissues, strains and developmental and hormonal states. Arch. Biochem. Biophys. 134, 76–89 (1969).PubMedCrossRefGoogle Scholar
  494. Neunhoeffer, O., Wilhelm, G., Lehmann, G.: Eine enzymatische Umlagerung cancerogener Nitros- amine. Z. Naturforsch. 25b, 302–307 (1970).Google Scholar
  495. Newberne, P.M.: Carcinogenicity of aflatoxin-contaminated peanut meals, p. 187–208. In: G.N. Wogan (ed.), Mycotoxins in foodstuffs. Cambridge, Mass.: M.I.T. Press 1965.Google Scholar
  496. Newberne, P.M., Butler, W.H.: Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals. A review. Cancer Res. 29, 236–250 (1969).PubMedGoogle Scholar
  497. Newberne, P.M., Rogers, A.E.: Rat colon carcinomas associated with aflatoxin and marginal vitamin A. J. nat. Cancer Inst. 50, 439–448 (1973).PubMedGoogle Scholar
  498. Newman, M. S., Blum, S.: A new cyclisation reaction leading to epoxides of aromatic hydrocarbons. J. Amer. chem. Soc. 86, 5598–5600 (1964).CrossRefGoogle Scholar
  499. O’Connor, P. J., Capps, M.J., Craig, A.W.: Comparative studies of the hepatocarcinogen N,N- dimethylnitrosamine in vivo: reaction sites in rat liver DNA and the significance of their relative stabilities. Brit. J. Cancer 27, 153–166 (1973).PubMedCrossRefGoogle Scholar
  500. O’Connor, P. J., Capps, M. J., Craig, A. W., Lawley, P.D., Shah, S. A.: Differences in the patterns of methylation in rat liver ribosomal ribonucleic acid after reaction in vivo with methyl methanesul- phonate and NN-dimethylnitrosamine. Biochem. J. 129, 519–528 (1972).PubMedGoogle Scholar
  501. Oesch, F., Kaubisch, N., Jerina, D.M., Daly, J.W.: Hepatic epoxide hydrase. Structure activity relationships for substrates and inhibitors. Biochemistry 10, 4858–4866 (1971).PubMedCrossRefGoogle Scholar
  502. Oesch, F., Jerina, D.M., Daly, J.W., Lu, A. Y.H., Kuntzman, R., Conney, A.H.: A reconstituted microsomal enzyme system that converts naphthalene to trans-1,2-dihydroxy-l,2-dihydronaphtha- lene via naphthalene-1,2-oxide: presence of epoxide hydrase activity in cytochrome P-450 and P-448 fractions. Arch. Biochem. Biophys. 153, 62–67 (1972).PubMedCrossRefGoogle Scholar
  503. Ogara, R.W., Brown, J.M., Whiting, M.G.: Induction of hepatic and renal tumors by topical application of aqueous extract of cycad nut to artificial skin ulcers in mice. Fed. Proc. 23, 1383 (1964).Google Scholar
  504. Okada, M., Suzuki, E.: Metabolism of butyl(4-hydroxybutyl) nitrosamine in rats. Gann 63, 391–392 (1972).PubMedGoogle Scholar
  505. Okada, Y., Streisinger, G., Owen, J. (EMRICH), Newton, J., Tsugita, A., Inouye, M.: Molecular basis of a mutational hot spot in the lysozyme gene of bacteriophage T4. Nature (Lond.) 236, 338–341 (1972).CrossRefGoogle Scholar
  506. Okano, T., Isobe, A., Matsumoto, H.: Charge transfer in the molecular interaction of carcinogenic 4-nitroquinoline 1-oxides and DNA, with special reference to analysis at the nucleoside level. Gann 67, 427–436 (1972).Google Scholar
  507. Ortwerth, B.J., Novelli, G.D.: Studies on the incorporation of L-ethionine-ethyl-l-14C into the transfer RNA of rat liver. Cancer Res. 29, 380–390 (1969).PubMedGoogle Scholar
  508. Osswald, H., Kruger, F.W.: Die cancerogene Wirkung von 1,2-dimethylhydrazin beim Goldham- ster. Arzneimittel-Forsch. 19, 1891–1892 (1969).Google Scholar
  509. Pardue, M.L., Gall, J.C.: Chromosomal localisation of mouse satellite DNA. Science 168, 1356–1358 (1970).PubMedCrossRefGoogle Scholar
  510. Parke, D.V.: The biochemistry of foreign compounds. Oxford, England: Pergamon Press 1968.Google Scholar
  511. Parmiani, G., Colnaghi, M.I., DELLA Porta, G.: Immunodepression during urethane and N- nitrosomethylurea leukaemogenesis in mice. Brit. J. Cancer 25, 354–364 (1971).PubMedCrossRefGoogle Scholar
  512. Pataki, J., Balik, R.: Relative carcinogenicity of some diethylbenz(a)anthracenes. J. med. Chem. 15, 905–909 (1972).PubMedCrossRefGoogle Scholar
  513. Pataki, J., Huggins, C.: Relation of methyl and ethyl substitution of benz(a)anthracene to carcinogenicity. In: Physico-Chemical Mechanisms of Carcinogenesis. The Jerusalem Symposia on quantum chemistry and biochemistry. Bergmann, E.D. and Pullmann, B. (eds.), vol. 1, p. 64–71 (1969a).Google Scholar
  514. Pataki, J., Huggins, C.: Molecular sites of substituents of benz(a)anthracene related to carcinogenicity. Cancer Res. 29, 506–509 (1969b).PubMedGoogle Scholar
  515. Patterson, D.S.P., Roberts, B. A.: The in vitro reduction of aflatoxins BJ and B2 by soluble avian liver enzymes. Food Cosmet. Toxicol. 9, 829–837 (1971).Google Scholar
  516. Pegg, A.E.: Studies on the ethylation of rat liver transfer ribonucleic acid after administration of L-ethionine. Biochem. J. 128, 59–68 (1972).PubMedGoogle Scholar
  517. Pfeiffer, S. E., Wechsler, W.: Biochemically differentiated neoplastic clone of Schwann cells. Proc. nat. Acad. Sci. (Wash.) 69, 2885–2889 (1972).CrossRefGoogle Scholar
  518. Platonow, N.: Effect of prolonged feeding of toxic groundnut meal in mice. Vet. Rec. 74, 589–590 (1964).Google Scholar
  519. Pochon, F., Brookes, P., Michelson, A. M.: Action of the carcinogen 7-bromomethylbenz(a)anthra- cene on DNA. Europ. J. Biochem. 21, 154–160 (1971).PubMedCrossRefGoogle Scholar
  520. Pochon, F., Michelson, A. M.: Action of the carcinogen 7-bromomethylbenz(a)anthracene on synthetic polynucleotides. Europ. J. Biochem. 21, 144–153 (1971).PubMedCrossRefGoogle Scholar
  521. Poirier, M. M., Miller, J. A., Miller, E.C.: The carcinogenic activities of N-hydroxy-2-acetylamino- fluorene and its metal chelates as a function of retention at the injection site. Cancer Res. 25, 527–533 (1965).PubMedGoogle Scholar
  522. Potter, V.R.: Recent trends in cancer biochemistry: the importance of fetal tissue. Canad. Cancer Conference 8, 9–30 (1968).Google Scholar
  523. Pound, A. W.: Carcinogenesis and cell proliferation. N. Z. med. J. 67, 88–99 (1968).PubMedGoogle Scholar
  524. Prehn, R.T.: Function of depressed imunologic reactivity during carcinogenesis. J. nat. Cancer Inst. 31, 791–805 (1963).PubMedGoogle Scholar
  525. Prehn, R. T.: The role of immunity as a homeostatic mechanism during oncogenesis. In: Endogenous factors influencing host-tumor response (Wissler, R. W., Dao, T. L., and Wood, S., eds.). Chicago: University of Chicago Press 1967.Google Scholar
  526. Preussmann, R., Druckrey, H., Ivankovic, S., Hodenberg, A. VON: Chemical structure and carcinogenicity of aliphatic hydrazo, azo and azoxy compounds and of triazenes, potential in vivo alkylat-ing agents. Ann. N. Y. Acad. Sci. 163, 697–716 (1969a).CrossRefGoogle Scholar
  527. Preussmann, R., Hodenberg, A. VON: Mechanism of carcinogenesis with L-aryl-3,3-dialkyltriazenes. II. in vitro alkylation of guanosine, RNA and DNA with aryl-monoalkyltriazenes to form 7- alkylguanine. Biochem. Pharmacol. 19, 1505–1508 (1970).Google Scholar
  528. Preussmann, R., Hodenberg, A. VON, Hengy, H.: Mechanism of carcinogenesis with l-aryl-3,3- dialkyltriazenes. Enzymatic dealkylation by rat liver microsomal fraction in vitro. Biochem. Pharmacol. 18, 1–13 (1969b).PubMedCrossRefGoogle Scholar
  529. Prodi, G., Rochi, P., Grilli, S.: Binding of 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene to nucleic acids and proteins of organs in rats. Cancer Res. 30, 1020–1023 (1970).PubMedGoogle Scholar
  530. Prough, R. A., Wittkop, J. A., Reed, D.J.: Evidence for the hepatic metabolism of some monoalkyl hydrazines. Biochim. biophys. Acta (Amst.) 131, 369–373 (1969).Google Scholar
  531. Prough, R.A., Wittkop, J.A., Reed, D.J.: Further evidence on the nature of microsomal metabolism of procarbazine and related alkylhydrazines. Arch. Biochem. Biophys. 140, 450–458 (1970).PubMedCrossRefGoogle Scholar
  532. Pullman, A.: Sur une relation entre les répartitions des charges électronique et le pouvoir cancérigène d’une certaine classe d’hydrocarbures. C. R. Acad. Sci. (Paris) 221, 140–142 (1945).Google Scholar
  533. Pullman, A., Pullman, B.: Electronic structure and carcinogenic activity of aromatic molecules: new developments. Advanc. Cancer Res. 3, 117–167 (1955).CrossRefGoogle Scholar
  534. Purchase, I.F.H.: Acute toxicity of anatoxins M1 and M2 in one-day-old ducklings. Food Cosmet. Toxicol. 5, 339–342 (1967).Google Scholar
  535. Purchase, I.F.M., Watt, J.J. VAN DER: Acute toxicity of sterigmatocystin to rats. Food Cosmet. Toxicol. 7, 135–139 (1969).Google Scholar
  536. Purchase, I.F.H., Watt, J.J. VAN DER: Carcinogenicity of sterigmatocystin. Food Cosmet. Toxicol. 8, 289–295 (1970).Google Scholar
  537. Radomski, J.L., Brill, E., Deichmann, W.B., Glass, E.M.: Carcinogenicity testing of N-hydroxy and other oxidation and decomposition products of 1- and 2-naphthylamine. Cancer Res. 31, 1461–1467 (1971).PubMedGoogle Scholar
  538. Radomski, J.L., Conzelman, G.M., Rey, A. A., Brill, E.: N-oxidation of certain aromatic amines, acetamides and nitro compounds by monkeys and dogs. J. nat. Cancer Inst. 50, 989–995 (1973).PubMedGoogle Scholar
  539. Rayman, M.P., Dipple, A.: Structure and activity in chemical carcinogenesis. Comparison of the reactions of 7-bromomethylbenz(a)anthracene and 7-bromomethyl-12-methylbenz(a)anthracene with deoxyribonucleic acid in vitro. Biochemistry 12, 1202–1207 (1973a).PubMedCrossRefGoogle Scholar
  540. Rayman, M.P., Dipple, A.: Structure and activity in chemical carcinogenesis. Comparison of the reactions of 7-bromomethylbenz(a)anthracene and 7-bromomethyl-12methylbenz(a)anthracene with mouse skin deoxyribonucleic acid in vivo. Biochemistry 12, 1538–1542 (1973b).PubMedCrossRefGoogle Scholar
  541. Riopelle, J.L., Jasmin, G.: Nature, classification and nomenclature of kidney tumors induced in the rat by dimethylnitrosamine. J. nat. Cancer Inst. 42, 643–662 (1969).PubMedGoogle Scholar
  542. Roberts, J. J., Warwick, G.P.: The reaction of /?-propiolactone with guanosine, deoxyguanylic acid and RNA. Biochem. Pharmacol. 12, 1441–1442 (1963).PubMedCrossRefGoogle Scholar
  543. Robinson, R.: Some aspects of chemistry related to medicine. Brit. med. J. 1946 I, 943–945.CrossRefGoogle Scholar
  544. Roe, F. J.C., Dipple, A., Mitchley, B.C. V.: Carcinogenic activity of some benz(a)anthracene derivatives in new born mice. Brit. J. Cancer 26, 461–465 (1972).PubMedCrossRefGoogle Scholar
  545. Roe, F.J.C., Glendenning, D.M.: The carcinogenicity of /?-propiolactone for mouse skin. Brit. J. Cancer 10, 357–362 (1956).PubMedCrossRefGoogle Scholar
  546. Roe, F.J.C., Grant, G.A., Millican, D.M.: Carcinogenicity of hydrazine and 1,1-dimethylhydra- zine for mouse lung. Nature (Lond.) 216, 375–376 (1967).CrossRefGoogle Scholar
  547. Rogers, A.E., Newberne, P.M.: Nutrition and aflatoxin carcinogenesis. Nature (Lond.) 229, 62–63 (1971).CrossRefGoogle Scholar
  548. Rosen, L.: Ethylation in vivo of purines in rat-liver RNA by L-ethionine. Biochem. biophys. Res. Commun. 33, 546–550 (1968).Google Scholar
  549. Ross, A. E., Keefer, L., Lijinsky, W.: Alkylation of nucleic acids of rat liver and lung by deuterated N-nitrosodiethylamine in vivo. J. nat. Cancer Inst. 47, 789–795 (1971).PubMedGoogle Scholar
  550. Ross, W.C.J.: Biological alkylating agents. London: Butterworths 1962.Google Scholar
  551. Roy, A.K.: Effects of aflatoxin Bi on polysome profiles and RNA synthesis in rat liver. Biochim. biophys. Acta (Amst.) 169, 206–211 (1968).Google Scholar
  552. Sander, J.: Untersuchungen über die Entstehung cancerogener Nitrosoverbindungen im Magen von Versuchstieren und ihre Bedeutung für den Menschen. Arzneimittel-Forsch. 21, 1572–1580, 1707–1713,2034–2039 (1971).Google Scholar
  553. Sanger, V.L., Yang, M.G., Mickelsen, O.: Cycad toxicosis in chickens. J. nat. Cancer Inst. 43, 391–395 (1969).PubMedGoogle Scholar
  554. Santamaria, L., Giordano, G.G., Alfisi, M., Cascione, F.: Effects of light on 3,4-benzpyrene carcinogenesis. Nature (Lond.) 210, 824–825 (1966).CrossRefGoogle Scholar
  555. Sarasin, A., Moule, Y.: In vivo effect of aflatoxin B1 on protein synthesis in rat liver. FEBS Letters 29, 329–332 (1973).PubMedCrossRefGoogle Scholar
  556. Sato, K., Poirier, L. A., Miller, J. A., Miller, E.C.: Studies on the N-hydroxylation and carcinogenicity of 4-aminoazobenzene and related compounds. Cancer Res. 26, 1678–1687 (1966).PubMedGoogle Scholar
  557. Sato, S., Matsushima, T., Tawaka, N., Sugimura, T., Takashima, F.: Hepatic tumours in the Guppy (Libistes reticulatus) induced by aflatoxin B1? dimethylnitrosamine and 2-acetylaminofluor- ene. J. nat. Cancer Inst. 50, 765–778 (1973).Google Scholar
  558. Satoh, T., Ide, T.: Strand scission and rejoining of DNA in cultured mammalian cells induced by 4-nitroquinoline 1-oxide. Cancer Res. 32, 1230–1235 (1972).Google Scholar
  559. Satoh, T., Yamamoto, N.: Repair mechanism in sendai virus carrying Hela cells after damage by 4-hydroxyaminoquinoline 1-oxide. Cancer Res. 32, 440–447 (1972).Google Scholar
  560. Saunders, F.C., Barker, E.A., Smuckler, E.A.: Selective inhibition of nucleoplasm rat liver DNA dependent RNA polymerase by aflatoxin B1# Cancer Res. 32, 2487–2494 (1972b).Google Scholar
  561. Scaife, J.F.: Aflatoxin BX: cytotoxic mode of action evaluated by mammalian cell cultures. FEBS Letters 12, 143–147(1971).PubMedCrossRefGoogle Scholar
  562. Schabort, J.C.: The differential interaction of Aflatoxins B1? and G2 with deoxyribonucleic acids from different sources. J. S. Afr. Chem. Inst. 22, 80–87 (1969).Google Scholar
  563. Schabort, J. C.: The differential interaction of aflatoxin B2 with deoxyribonucleic acids from different sources and with purines and purine nucleosides. Chem.-Biol. Interactions 3, 371–382 (1971).Google Scholar
  564. Schabort, J.C., Steyn, M.: Substrate and phenobarbital inducible aflatoxin-4-hydroxylation and aflatoxin metabolism by rat liver microsomes. Biochem. Pharmacol. 18, 2241–2252 (1969).PubMedCrossRefGoogle Scholar
  565. SCHMÄHl, D., KRÜGer, F.W.: Influence of disulfiram (tetraethylfluiramdisulfide) on the biological actions of N-nitrosamines. In: Topics in chemical carcinogenesis (Nakahara, W., Takayama, S., Sugimura, T., and Odashima, S., eds.), p. 199–211. Tokyo: University of Tokyo Press 1972.Google Scholar
  566. SCHMÄHl, D., Osswald, H.: Carcinogenesis in different animal species by diethylnitrosamine. Expe- rientia (Basel) 23, 497 (1967).CrossRefGoogle Scholar
  567. SCHMÄHl, D., Thomas, C.: Die akute Vergiftung der Ratte mit Nitrosomethylurethan nach oraler Applikation. Arzneimittel-Forsch. 12, 585–587 (1962).Google Scholar
  568. Schmidt, O.: Characterisierung und Mechanismus der Krebs erzeugenden Kohlenwasserstoffe. Natur-wissenschaften 29, 146–150 (1941).CrossRefGoogle Scholar
  569. Schoental, R.: Hepatotoxic action of pyrrolizidine (senecio) alkaloids in relation to their structure. Nature (Lond.) 179, 361–363 (1957).CrossRefGoogle Scholar
  570. Schoental, R.: Carcinogenic action of diazomethane and of nitroso-N-methyl urethane. Nature (Lond.) 188, 420–421 (1960).CrossRefGoogle Scholar
  571. Schoental, R.: Toxicology and carcinogenic action of pyrrolizidine alkaloids. Cancer Res. 28, 2237–2246(1968).PubMedGoogle Scholar
  572. Schoental, R.: Lack of correlation between the presence of 7-methylguanine in deoxyribonucleic acid and ribonucleic acid of organs and the localisation of tumours after a single carcinogenic dose of N-methyl-N-nitrosourethane. Biochem. J. 114, 55P-56P (1969).PubMedGoogle Scholar
  573. Schoental, R.: Hepatotoxic activity of retrorsine, senkirkine and hydroxysenkirkine in newborn rats and the role of epoxides in carcinogenesis by pyrrolizidine alkaloids and aflatoxins. Nature (Lond.) 227, 401–402 (1970).CrossRefGoogle Scholar
  574. Schoental, R.: Brain and spinal cord tumours in rats treated with pyrrolizidine alkaloids. J. nat. Cancer Inst. 49, 665–671 (1972).PubMedGoogle Scholar
  575. Schoental, R., Fowler, M.E., Coady, A.: Islet cell tumours of the pancreas found in rats given pyrrolizidine alkaloids from Amsinkia intermedia Fisch and Mey and from Heliotropium supinum L. Cancer Res. 30, 2127–2131 (1970).PubMedGoogle Scholar
  576. Schoental, R., Hard, G.C., Gibbard, S.: Histopathology of renal lipomatous tumours in rats treated with the “natural” products, pyrrolizidine alkaloids and a,-unsaturated aldehydes. J. nat. Cancer Inst. 47, 1037–1044(1971).PubMedGoogle Scholar
  577. Schoental, R., Head, M.A., Peacock, P.R.: Senecio alkaloids: primary liver tumours in rats as a result of treatment with 1) a mixture of alkaloids from S. Jacobea L. 2) retrorsine 3) isatidine. Brit. J. Cancer 8, 458–465 (1954).PubMedCrossRefGoogle Scholar
  578. Schoental, R., Magee, P.N.: Induction of squamous carcinoma of the lung and of the stomach and oesophagus by diazomethane and N-methyl-N-nitroso-urethane respectively. Brit. J. Cancer 16, 92–100 (1962).PubMedCrossRefGoogle Scholar
  579. Schoental, R., Mattocks, A.R.: Hepatotoxic activity of semisynthetic analogues of pyrrolizidine alkaloids. Nature (Lond.) 185, 842–843 (1960).CrossRefGoogle Scholar
  580. Schoental, R., RIVE. D.J.: Interaction of N-alkyl-N-nitroso-urethanes with thiols. Biochem. J. 97, 466–474 (1965).PubMedGoogle Scholar
  581. Schreiber, D., Warzok, R., Scholtze, P., Schneider, J., Lageman, A., Batke, H.: Das Spektrum extraneuraler Tumoren bei Ratten nach Applikation von N-Methyl-N-nitrosoharnoff. Zbl. allg. Path. path. Anat. 115, 48–61 (1972).Google Scholar
  582. Scribner, J. D.: Formation of a sigma complex as a hypothetical rate determining step in the carcinogenic action of unsubstitutedpolycyclic aromatic hydrocarbons. Cancer Res. 29, 2120–2126 (1969).PubMedGoogle Scholar
  583. Scribner, J. D., Miller, J.A, Miller, E. C.: Nucleophilic substitution on carcinogenic N-acetoxy-N- arylacetamides. Cancer Res. 30, 1570–1579 (1970).PubMedGoogle Scholar
  584. Searle, C. E., Jones, E. L.: Tumours of the nervous system in mice treated neonatally with N-ethyl-N- nitrosourea. Nature (Lond.) 240, 559–560 (1972).CrossRefGoogle Scholar
  585. Selkirk, J.K., Huberman, E., Heidelberger, C: An epoxide is an intermediate in the microsomal metabolism of the chemical carcinogen dibenz(a,h)anthracene. Biochem. biophys. Res. Comm. 43, 1010–1016 (1971).Google Scholar
  586. Shank, R.C.: Effect of cycasin on protein synthesis. Biochim. biophys. Acta(Amst.) 166,578–580 (1968).Google Scholar
  587. Shank, R.C., Magee, P.N.: Similarities between the biochemical actions of cycasin and dimethyl- nitrosamine. Biochem. J. 105, 521–527 (1967).PubMedGoogle Scholar
  588. Shear, M.J.: Studies in carcinogenesis V. Methyl derivatives of 1,2-benzanthracene. Amer. J. Cancer 33, 499–537 (1938).Google Scholar
  589. Shear, M. J., Leiter, J.: Studies in carcinogenesis. XV. Compounds related to 20-methylcholanthrene. J. nat. Cancer Inst. 2, 99–113 (1941).Google Scholar
  590. Shimkin, M.B.: Pulmonary-tumour induction in mice with chemical agents used in the clinical management of lymphomas. Cancer (Philad.) 7, 410–413 (1954).CrossRefGoogle Scholar
  591. Shimkin, M.B., Weisburger, J.H., W., eisburger, E.K., Gubareff, N., Suntzeff, V.: Bioassay of 29 alkylating chemicals by the pulmonary-tumor response in strain A mice. J. nat. Cancer Inst. 36,915–935 (1966).Google Scholar
  592. Shirasu, Y., Ohta, A.: A preliminary note on the carcinogenicity of 4-hydroxyaminoquinoline 1-oxide. Gann 54, 221–223 (1963).PubMedGoogle Scholar
  593. Shull, K.H., Mcconomy, J., Vogt, M., Castillo, A., Farber, E.: On the mechanism of induction of hepatic adenosine triphosphate deficiency by ethionine. J. biol. Chem. 241, 5060–5070 (1966).PubMedGoogle Scholar
  594. Sims, P.: The metabolism of 3-methylcholanthrene and some related compounds by rat liver homo- genates. Biochem. J. 98, 215–228 (1966).PubMedGoogle Scholar
  595. Sims, P.: The carcinogenic activities in mice of compounds related to 3-methylcholanthrene. Int. J. Cancer 2, 505–508 (1967a).PubMedCrossRefGoogle Scholar
  596. Sims, P.: The metabolism of 7- and 12-methylbenz(a)anthracene and their derivatives. Biochem. J. 105, 591–598 (1967b).PubMedGoogle Scholar
  597. Sims, P.: The metabolism of benzo(a)pyrene by rat liver homogenates. Biochem. Pharmacol. 16, 613–618 (1967c).PubMedCrossRefGoogle Scholar
  598. Sims, P.: Qualitative and quantitative studies on the metabolism of a series of aromatic hydrocarbons by rat liver preparations. Biochem. Pharmacol. 19, 795–818 (1970a).PubMedCrossRefGoogle Scholar
  599. Sims, P.: The metabolism of some aromatic hydrocarbons by mouse embryo cell cultures. Biochem. Pharmacol. 19, 285–297 (1970b).PubMedCrossRefGoogle Scholar
  600. Sims, P.: Epoxy derivatives of aromatic polycyclic hydrocarbons. The preparation of benz(a)anthra- cene 8,9-oxide and 10,11-dihydrobenz(a)anthracene 8,9-oxide and their metabolism by rat liver preparations. Biochem. J. 125, 159–168 (1971).PubMedGoogle Scholar
  601. Singer, B., FRAENKEL-Conrat, H: Messenger and template activities of chemically modified polynu-cleotides. Biochemistry 9, 3694–3701 (1970).PubMedCrossRefGoogle Scholar
  602. Sinnhuber, R.O., Lee, D.J., Wales, J.H., Ayres, J.L.: Dietary factors and hepatoma in rainbow trout (Salmo gairdneri). II. Cocarcinogenesis by cyclopropenoid fatty acids and the effect of gossypol and altered lipids on aflatoxin-induced liver cancer. J. nat. Cancer Inst. 41, 1293–1299 (1968).PubMedGoogle Scholar
  603. Smith, D.W.E.: Mutagenicity of cycasin aglycone (methylazoxymethanol), a naturally occurring carcinogen. Science 152, 1273–1274(1966).PubMedCrossRefGoogle Scholar
  604. Smith, R.C., Salmon, W.D.: Formation of S-adenosylethionine by ethionine treated rats. Arch. Biochem. Biophys. 111, 191–196(1965).PubMedCrossRefGoogle Scholar
  605. Somogi, A., Conney, A.H., Kuntzman, R., Solymos, B.: Protection against dimethylnitrosamine toxicity by pregnenolone-16a-carbonitrile. Nature (Lond.) New Biol. 237, 61–62 (1972).CrossRefGoogle Scholar
  606. Sorof, S., Kish, V. M., Sani, B.: Purification and properties of the principle liver protein conjugate of a hepatic carcinogen. Biochem. biophys. Res. Commun. 48, 860–865 (1972).Google Scholar
  607. Sorof, S., Young, E.M., Mccue, M.M., Fetterman, P.L.: Zonal eletrophoresis of the soluble proteins of liver and tumour in azo dye carcinogenesis. Cancer Res. 23, 864–882 (1967).Google Scholar
  608. Sorof, S., Young, E.M., Mcbride, R.A., Coffey, C.B.: On protein targets of chemical carcinogens: dissimilar molecular sizes of the principal protein conjugates. Cancer Res. 30, 2029–2034 (1970).PubMedGoogle Scholar
  609. Spatz, M.: Carcinogenic effect of cycad meal in guinea pigs. Fed. Proc. 23, 1384–1385 (1964).PubMedGoogle Scholar
  610. Spatz, M.: Hydrolysis of cycasin by /?-D-glucosidase in skin of newborn rats. Proc. Soc. exp. Biol. (N. Y.) 128, 1005–1008 (1968).Google Scholar
  611. Spatz, M.: Toxic and carcinogenic alkylating agents from cycads. Ann. N. Y. Acad. Sci. 163, 848–859 (1969).CrossRefGoogle Scholar
  612. Spatz, M., Dougherty, W.J., Smith, D.W.E.: Teratogenic effects of methylazoxymethanol. Proc. Soc. exp. Biol. (N. Y.) 124, 476–478 (1967a).Google Scholar
  613. Spatz, M., Laqueur, G.L.: Transplacental induction of tumours in Sprague-Dawley rats with crude cycad material. J. nat. Cancer Inst. 38, 233–245 (1967).PubMedGoogle Scholar
  614. Spatz, M., Laqueur, G.L.: Evidence for transplacental passage of the natural carcinogen, cycasin and its aglycone. Proc. Soc. exp. Biol. (N.Y.) 127, 281–286 (1968a).Google Scholar
  615. Spatz, M., Laqueur, G.L.: Transplacental chemical induction of microencephaly in two strains of rats. Proc. Soc. exp. Biol. (N.Y.) 129, 705–710 (1968b).Google Scholar
  616. Spatz, M., Laqueur, G.L., Holmes, J.M.: Carcinogenic effects of methylazoxymethanol (MAM) in hamsters. Proc. Amer. Ass. Cancer Res. 10, 86 (1969).Google Scholar
  617. Spatz, M., Mcdaniel, E.G., Laqueur, G.L.: Cycasin excretion in conventional and germfree rats. Proc. Soc. exp. Biol. (N.Y.) 121, 417–422 (1966).Google Scholar
  618. Spatz, M., Smith, D.W.E., Mcdaniel, E.G., Laqueur, G.L.: Role of intestinal microorganisms in determining cycasin toxicity. Proc. Soc. exp. Biol. (N.Y.) 124, 691–697 (1967b).Google Scholar
  619. Spjut, H. J., Noall, M. W.: Experimental induction of tumours of the large bowel of rats. A review of the experience with 3–2/dimenthyl-4-aminobiphenyl. Cancer (Philad.) 1, 29–37 (1971).CrossRefGoogle Scholar
  620. Sporn, M.B., Dingman, C. W.: 2-Acetamidofluorene and 3-methylcholanthrene: differences in binding to rat liver DNA in vivo. Nature (Lond.) 210, 531–532 (1966).CrossRefGoogle Scholar
  621. Sporn, M. B., Dingman, C. W., Phelps, H. L., Wogan, G. N.: Aflatoxin Bj: Binding to DNA in vitro and alteration of RNA metabolism in vivo. Science 151, 1539–1541 (1966).PubMedCrossRefGoogle Scholar
  622. Stanton, M. F.: Hepatic neoplasms of aquarium fish exposed to Cycas Circinalis. Fed. Proc. 25, 661 (1966).Google Scholar
  623. Starr, J.L., Sells, B.H.: Methylated ribonucleic acids. Physiol. Revs. 49, 623–669 (1969).Google Scholar
  624. Stekol, J.A.: Formation and metabolism of S-adenosyl derivatives of S-alkyl homocysteines in the rat and mouse. In: Transmethylation and biosynthesis of methionine (Shapiro, S.K., and Schlenk, F., eds.), p. 235–252. Chicago: Chicago University Press 1965.Google Scholar
  625. Stekol, J. A., Mody, U., Perry, J.: The incorporation of the carbon of the ethyl group of ethionine into liver nucleic acids and the effect of ethionine feeding on the content of nucleic acids in rat liver. J. biol. Chem. 235, PC59-PC60 (1960).Google Scholar
  626. Stewart, B.W., Swann, P.F., Holsman, J.W., Magee, P.N.: Cellular injury and carcinogenesis. Evidence for the alkylation of rat liver nucleic acids in vivo by N-nitrosomorpholine. Z. Krebs- forsch 81, 1–12 (1974).CrossRefGoogle Scholar
  627. Stich, H. F., San, R. H. C.: Reduced DNA repair synthesis in Xeroderma Pigmentosum cells exposed to the oncogenic 4-nitroquinoline 1-oxide and 4-hydroxyaminoquinoline 1-oxide. Mutation Res. 13,279–282 (1971).CrossRefGoogle Scholar
  628. Stich, H.F., San, R.H.C., Dawazoe, Y.: DNA repair synthesis in mammalian cells exposed to a series of oncogenic and non-oncogenic derivatives of 4-nitroquinoline-1-oxide. Nature (Lond.) 229,416–419 (1971).CrossRefGoogle Scholar
  629. StjernswÄrd, J.: Immunosuppression by carcinogens. Antibiot. and Chemother. (Basel) 15, 213–233 (1969).Google Scholar
  630. SüSs, R.: Zur Wirkungsweise der Nitrosamine. Z. Naturforsch. 20b, 714 (1965).Google Scholar
  631. SüSs, R., Maurer, H.R.: Reduced binding of a carcinogenic hydrocarbon to DNA of mouse skin during inhibition of DNA synthesis. Nature (Lond.) 217, 752–753 (1968).CrossRefGoogle Scholar
  632. SÜSsmuth, R., Haerlin, R., Lingens, F.: The mode of action of N-methyl-N’-nitro-N-nitrosoguani- dine in mutagenesis. VII. The transfer of the methyl group of N-methyl-N’-nitro-N-nitrosguani- dine. Biochim. biophys. Acta (Amst.) 269, 276–286 (1972).Google Scholar
  633. Sugimura, T., Kawachi, T.: Experimental stomach cancer. Meth. Cancer Res. 7, 245–308 (1973).Google Scholar
  634. Sugimura, T., Okabe, K., Nagao, M.: The metabolism of 4-nitroquinoline 1-oxide, a carcinogen. III. An enzyme catalysing the conversion of 4-nitroquinoline-1-oxide to 4-hydroxylaminoquino- line-1-oxide in rat liver and hepatomas. Cancer Res. 26, 1717–1721 (1966).PubMedGoogle Scholar
  635. Sugimura, T., Otake, H., Matsushima, T.: Single strand scissions of DNA caused by a carcinogen, hydroxylaminoquinoline 1-oxide. Nature (Lond.) 218, 392 (1968).CrossRefGoogle Scholar
  636. Sullman, S.F., Armstrong, S.J., Zuckerman, A. J., Rees, K.R.: Further studies of the toxicity of aflatoxins on human cell cultures. Brit. J. exp. Path. 51, 314–316 (1970).PubMedGoogle Scholar
  637. Sung, S.S.: Essai d’application de la theorie des regions K et L a un nouveau lot d’hydrocarbures aromatiques polycycliques. C.R. Acad. Sci. (Paris), Ser D 273, 1247–1250 (1971).Google Scholar
  638. Sung, S.S.: Essai d’application de la theorie des regions K et L a un nouveau lot d’hydrocarbures aromatiques polycycliques. Etude avec les indices complexes de reactivite. C. R. Acad. Sci. 274, 1597–1600 (1972).Google Scholar
  639. Sunshine, G.H., Williams, D.J., Rabin, B.R.: Role for steroid hormones in the interaction of ribo- somes with the endoplasmic membranes of rat liver. Nature (Lond.) New Biol. 230, 133–136 (1971).Google Scholar
  640. Svoboda, D. J., Reddy, J. K.: Malignant tumours in rats given lasiocarpine. Cancer Res. 32, 908–912 (1972).PubMedGoogle Scholar
  641. Swann, P. F.: The rate of breakdown of methyl methanesulphonate, dimethyl sulphate and N-methyl- N-nitrosourea in the rat. Biochem. J. 110, 49–52 (1968).PubMedGoogle Scholar
  642. Swann, P. F., Mclean, A.E.M.: Cellular injury and carcinogenesis. The effect of a protein-free high-carbohydrate diet on the metabolism of dimethylnitrosamine in the rat. Biochem. J. 124, 283–288 (1971).PubMedGoogle Scholar
  643. Swann, P. F., Magee, P.N.: Nitrosamine-induced carcinogenesis. The alkylation of nucleic acids of the rat by N-methyl-N-nitrosourea, dimethylnitrosamine, dimethyl sulphate and methyl meth-anesulphonate. Biochem. J. 110, 39–47 (1968).PubMedGoogle Scholar
  644. Swann, P. F., Magee, P.N.: Induction of rat kidney tumours by ethyl methanesulphonate and nervous tissue tumours by methyl methanesulphonate and ethyl methansulphonate. Nature (Lond.) 223, 947–948 (1969).CrossRefGoogle Scholar
  645. Swann, P. F., Magee, P.N.: Nitrosamine induced carcinogenesis. The alkylation of N-7 of guanine of nucleic acids of the rat by diethylnitrosamine, N-ethyl-N-nitrosourea and ethyl methanesulphonate. Biochem. J. 125, 841–847 (1971).PubMedGoogle Scholar
  646. Swann, P.F., Pegg, A.E., Hawks, A., Farber, E., Magee, P.N.: Evidence for ethylation of rat liver deoxyribonucleic acid after administration of ethionine. Biochem. J. 123, 175–181 (1971).PubMedGoogle Scholar
  647. Swenson, D.H., MILLER, J.A., MILLER, E.C.: 2,3-dihydro-2,3-dihydroxy-aflatoxin Bj: An acid hydrol-. ysis product of a RNA-aflatoxin Bx adduct formed by hamster and rat liver microsomes in vitro. Biochem. biophys. Res. Commun. 53, 1260–1267 (1973).Google Scholar
  648. Szafarz, D., Weisburger, J. H.: Stability of binding of label from AMiydroxy-Af-2-fluorenylacetamide to intracellular targets, particularly deoxyribonucleic acid in rat liver. Cancer Res. 29, 962–968 (1969).PubMedGoogle Scholar
  649. Tada, M.: Interaction of a carcinogen, 4-hydroxyaminoquinoline 1-oxide with nucleic acid. Biochem. biophys. Res. Commun. 29, 469–477 (1967).Google Scholar
  650. Tasseron, J.G., Diringer, H., Frowirth, N., Mirvish, S.S., Heidelberger, C.: Partial purification of soluble protein from mouse skin to which carcinogenic hydrocarbons are specifically bound. Biochemistry 9, 1636–1644(1970).PubMedCrossRefGoogle Scholar
  651. Teas, H. J., Dyson, J.G.: Mutation in Drosophila by methylazoxymethanol, the aglycone of cycasin. Proc. Soc. exp. Biol. (N. Y.) 125, 988–990 (1967).Google Scholar
  652. Teas, H. J., Sak, H. J., Sax, K.: Cycasin: Radiomimetic effect. Science 149, 541–542 (1965).PubMedCrossRefGoogle Scholar
  653. Temin, H.M.: The protovirus hypothesis: speculations on the significance of RNA directed DNA synthesis for normal development and for carcinogenesis. J. nat. Cancer Inst. 46, III-VII (1971).Google Scholar
  654. Thomas, C., Schmahl, D.: Zur Morphologie der Nierentumoren bei der Ratte. Z. Krebsforsch. 66, 125–137(1964).PubMedGoogle Scholar
  655. Todaro, G.J., Huebner, R.J.: The viral oncogenic hypothesis: new evidence. Proc. nat. Acad. Sci. (Wash.) 69, 1009–1015 (1972).CrossRefGoogle Scholar
  656. Toth, B.: Tumorigenesis studies with 1,2-dimethylhydrazine dihydrochloride, hydrazine sulphate and isonicotinic acid in golden hamsters. Cancer Res. 32, 804–807 (1972a).PubMedGoogle Scholar
  657. Toth, B.: Morphological studies of angiosarcomas induced by 1,2-dimethylhydrazine dihydrochloride in Syrian golden hamsters. Cancer Res. 32, 2818–2827 (1972b).PubMedGoogle Scholar
  658. Toth, B.: Comparative studies with hydrazine derivatives: carcinogenicity of 1,1-dimethylhydrazine, unsymmetrical (1,1-DMH) in the blood vessels, lungs, kidneys and liver of Swiss mice. Proc. Amer. Ass. Cancer Res. 13, 34 (1972c).Google Scholar
  659. Toth, B., Wilson, R.B.: Blood vessel tumorigenesis by 1,2-dimethylhydrazine dihydrochloride (sym-metrical). Amer. J. Path. 64, 585–600 (1971).PubMedGoogle Scholar
  660. Troll, W., Belman, S., Berkowitz, E., Chmielewicz, Z.F., Ambrus, J.L., Bardos, T.J.: Differential responses of DNA and RNA polymerase to modifications of the template rat liver DNA caused by action of the carcinogen, acetylaminofluorene, in vivo and in vitro. Biochim. biophys. Acta (Amst.) 157, 16–24(1968).Google Scholar
  661. Troll, W., Rinde, E., Day, P.: Effect of N-7 and C-8 substitution of guanine in DNA on TM, buoyant density and RNA polymerase priming. Biochim. biophys. Acta (Amster.) 174, 211–219 (1969).Google Scholar
  662. Ts’O, P.O. P., Lu, P.: Interaction of nucleic acids. II. Chemical linkage of the carcinogen 3,4-benzpyr- ene to DNA induced by photoradiation. Proc. nat. Acad. Sci. (Wash.) 51, 272–280 (1964).CrossRefGoogle Scholar
  663. Tsutsui, E., Srinivasan, P.R., Borek, E.: tRNA methylases in tumours of animal and human origin. Proc. nat. Acad. Sci. (Wash.) 56, 1003–1009 (1966).CrossRefGoogle Scholar
  664. Turberville, C., Craddock, V. M.: Methylation of nuclear proteins by dimethylnitrosamine and by methionine in the rat in vivo. Biochem. J. 124, 725–739 (1971).PubMedGoogle Scholar
  665. Uehleke, H.: N-hydroxylation. Xenobiotica 1, 327–338 (1971).PubMedCrossRefGoogle Scholar
  666. Umans, R.S., Lesko, S.A., Ts’O, P.O.P.: Chemical linkage of carcinogenic 3,4-benzpyrene to DNA in aqueous solution induced by peroxide and iodine. Nature (Lond.) 221, 763–764 (1969).CrossRefGoogle Scholar
  667. Umeda, M., Diringer, H., Heidelberger, C.: Inhibition of the growth of cultured cells by arginase and the soluble protein from mouse skin. Israel J. med. Sci. 4, 1216–1222 (1968).Google Scholar
  668. Unuma, T., Harris, H.P., Busch, H.: Comparative studies of the nucleoli of Morris hepatomas, embryonic liver and aflatoxin Bx-treated liver of rats. Cancer Res. 27, 2221–2233 (1967).PubMedGoogle Scholar
  669. VAN Duuren, B.L.,: Biological effects of alkylating agents. Ann. N. Y. Acad. Sci. 163, 589–1029 (1969).Google Scholar
  670. VAN Duuren, B.L., Langseth, L., Goldschmidt, B.M., Orris, L.: Carcinogenicity of epoxides, lactones, and peroxy compounds. VI. Structure and carcinogenic activity. J. nat. Cancer Inst. 39, 1217–1228 (1967).PubMedGoogle Scholar
  671. VAN Duuren, S.L., Sivak, A., Goldschmidt, B.M., Katz, C., Melchionne, S.: Carcinogenicity of halo-ethers. J. nat. Cancer Inst. 43, 481–486 (1969).PubMedGoogle Scholar
  672. VAN Duuren, B.L., Sivak, A., Goldschmidt, B.M., Katz, C., Melchionne, S.: Initiating activity of aromatic hydrocarbons in two stage carcinogenesis. J. nat. Cancer Inst. 44, 1167–1173 (1970).PubMedGoogle Scholar
  673. Venkatesan, N., Arcos, J.C., Argus, M.F.: Differential effect of polycyclic hydrocarbons on the demethylation of the carcinogen dimethylnitrosamine by rat tissues. Life Sci. 7, 1111–1119 (1968).PubMedCrossRefGoogle Scholar
  674. Venkatesan, N., Arcos, J.C., Argus, M.F.: Amino acid induction and carbohydrate repression of dimethylnitrosamine demethylase in rat liver. Cancer Res. 30, 2563–2567 (1970a).PubMedGoogle Scholar
  675. Venkatesan, N., Argus, M. F., Arcos, J. C.: Mechanism of 3-methylcholanthrene-induced inhibition of dimethylnitrosamine demethylase in rat liver. Cancer Res. 30, 2556–2562 (1970b).PubMedGoogle Scholar
  676. Vesselinovitch, S.D., Mihailovich, N., Wogan, G.N., Lombard, L.S., Rao, K.V.N.: Aflatoxin B1? a hepatocarcinogen in the infant mouse. Cancer Res. 32, 2289–2291 (1972).PubMedGoogle Scholar
  677. Vogel, E., Klarner, F.-G.: 1,2-naphthalene oxide. Angew. Chem. internat. Edit. 7, 374–375 (1968).CrossRefGoogle Scholar
  678. Wagner, L., Drews, J.: The effect of aflatoxin B on RNA synthesis and breakdown in normal and regenerating rat liver. Europ. J. Cancer 6, 465–476 (1970).CrossRefGoogle Scholar
  679. Wales, J. H., Sinnhuber, R. O.: Hepatomas induced by aflatoxin in the sockeye salmon (Oncorhynchus nerka). J. nat. Cancer Inst. 48, 1529–1530 (1972).PubMedGoogle Scholar
  680. Wang, I.Y., Rasmussen, R.E., Crocker, T.T.: Isolation and characterisation of an active DNA- binding metabolite of benzo(a)pyrene from hamster liver microsomal incubation systems. Biochem. biophys. Res. Commun. 49, 1142–1149 (1972).Google Scholar
  681. Warwick, G.P.: The mechanism of action of alkylating agents. Cancer Res. 23, 1315–1333 (1963).PubMedGoogle Scholar
  682. Warwick, G.P., Roberts, J.J.: Persistent binding of butter yellow metabolites to rat liver DNA. Nature (Lond.) 213, 1206–1207 (1967).CrossRefGoogle Scholar
  683. Waterfall, J.F., Sims, P.: Epoxy derivatives of aromatic polycyclic hydrocarbons. The preparation and metabolism of epoxides related to benzo(a)pyrene and to 7,8- and 9,10-dihydrobenzo(a)pyrene. Biochem. J. 128, 265–277 (1972).PubMedGoogle Scholar
  684. Wattenberg, L. W.: Enzymatic reactions and carcinogenesis. In: Environment and Cancer. (A collection of papers presented at the twenty fourth Annual Symposium on Fundamental Cancer Research, 1971 at the University of Texas, M.D. Anderson Hospital and Tumor Institute at Houston), p. 241–255. Baltimore Maryland: Williams and Wilkins Co. 1972.Google Scholar
  685. Wattenberg, L.W., Leong, J.L.: Histochemical demonstration of reduced pyridine nucleotide dependent polycyclic hydrocarbon metabolising systems. J. Histochem. Cytochem. 10, 412–420 (1962).CrossRefGoogle Scholar
  686. Wattenberg, L.W., Leong, J.: Inhibition of 9,10-dimethyl-benzanthracene (DMB) induced mammary tumorigenesis by phenothiazines. Fed. Proc. 26, 692 (1967).Google Scholar
  687. Wattenberg, L. W., Leong, J.: Inhibition of the carcinogenic action of 7,12-dimethylbenz(a)anthra- cene by beta-naphthoflavone. Proc. Soc. exp. Biol. (N. Y.) 128, 940–943 (1968).Google Scholar
  688. Wattenberg, L. W., Leong, J.: Inhibition of the carcinogenic action of benzo(a)pyrene by flavones. Cancer Res. 30, 1922–1925 (1970).PubMedGoogle Scholar
  689. Wattenberg, L. W., Leong, J. L.: Tissue distribution studies of polycyclic hydrocarbon hydroxylase activity. In: Handbuch der experimentellen Pharmakologie, vol. 28, ed. Brodie, B.B., and Gillette, J.R., p. 422–430. Berlin-Heidelberg-New York: Springer 1971.Google Scholar
  690. Wechsler, W., Kleihues, P., Matsumoto, S., Zulch, K. J., Ivankovic, S., Preussmann, R., DRUCK- REY, H.: Pathology of experimental neurogenic tumors chemically induced during prenatal and postnatal life. Ann. N. Y. Acad. Sci. 159, 360–408 (1969).CrossRefGoogle Scholar
  691. Wechsler, W., Pfeiffer, S.E., Swenberg, J.A., Koestner, A.: S-100 protein in tumors of central and peripheral nervous systems of rats induced by nitroso ureas. J. Neuropath, exp. Neurol. 31, 203 (1972a).Google Scholar
  692. Wechsler, W., Ramadan, M. A., Giesler, A.: Isogenic transplantation of ethylnitrosourea-induced tumors of the central and peripheral nervous system in two different inbred rat strains. Naturwissen- schaften 59, 474 (1972b).CrossRefGoogle Scholar
  693. Weigert, F., Mottram, J. C.: The biochemistry of benzpyrene. Part II. The course of its metabolism and the chemical nature of the metabolites. Cancer Res. 6, 109–120 (1946).PubMedGoogle Scholar
  694. Weinstein, I.B., Grunberger, D., Fujimura, S., Fink, L.M.: Chemical carcinogens and RNA. Cancer Res. 31, 651–655 (1971).PubMedGoogle Scholar
  695. Weisburger, E. K., Weisburger, J. H.: Chemistry, carcinogenicity and metabolism of 2-fluorenamine and related compounds. Advanc. Cancer Res. 5, 333–432 (1958).Google Scholar
  696. Weisburger, J.H.: Colon carcinogens: their metabolism and mode of action. Cancer (Philad.) 28, 60–70(1971).CrossRefGoogle Scholar
  697. Weisburger, J.H.: Model studies on the etiology of colon cancer. In: Topics in chemical carcinogenesis (Nakahara, W., Takayama, S., Sugimura, T., Odashima, S., eds.), p. 159–170. Tokyo: University of Tokyo Press 1972.Google Scholar
  698. Weisburger, J.H., Weisburger, E.K.: Biochemical formation and pharmacological, toxicological and pathological properties of hydroxylamine and hydroxamic acids. Pharmacol. Rev. 25, 1–66 (1973).PubMedGoogle Scholar
  699. Weisburger, J.H., Yamamoto, R.S., Williams, G.M., Grantham, P.H., Matsushima, T., WEIS-Burger, E. K.: On the sulfate ester of AMiydroxy-N-2-fluorenylacetamide as a key ultimate hepato- carcinogen in the rat. Cancer Res. 32, 491–500 (1972).PubMedGoogle Scholar
  700. Wheatley, D.N.: Enhancement and inhibition of the induction by 7,12-dimethylbenz(a)anthracene of mammary tumours in female Sprague Dawley rats. Brit. J. Cancer 22, 787–797 (1968).PubMedCrossRefGoogle Scholar
  701. Wheatley, D.N., Inglis, M.S.: Mammary tumours induced in Sprague-Dawley female rats by 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives. Brit. J. Cancer 22, 122–127 (1968).PubMedCrossRefGoogle Scholar
  702. White, I.N.H., Mattocks, A.R.: Reaction of dihydropyrrolizines with deoxyribonucleic acids in vitro. Biochem. J. 128, 291–297 (1972).PubMedGoogle Scholar
  703. Whiting, M.G.: Toxicity of cycads. Econ. Bot. 17, 271–302 (1963).CrossRefGoogle Scholar
  704. Whiting, M., Spatz, M., Matsumoto, H.: Research progress on cycads. Econ. Bot. 20, 98–102 (1966).CrossRefGoogle Scholar
  705. Whittle, E. D.: Methylation of rat-liver RNA in vivo by methyl methanesulphonate. Biochim. bio- phys. Acta (Amst.) 195, 381–388 (1969).Google Scholar
  706. Wiebecke, B., Lohrs, U., Gimmy, J., Eder, M.: Erzeugung von Darmtumoren bei Mäusen durch 1,2-Dimethylhydrazin. Z. ges. exp. Med. 149, 277–278 (1969).CrossRefGoogle Scholar
  707. Wiest, W.G., Heidelberger, C: The interaction of carcinogenic hydrocarbons with tissue constituents. II. 1,2,5,6-dibenzanthracene-9,10-C14 in skin. Cancer Res. 13, 250–254 (1953).PubMedGoogle Scholar
  708. Wilk, M., Bez, W., Rochlitz, J.: Neue Reactionen der carcinogenen Kohlenwasserstoffe 3,4-benz- pyren, 9,10-Dimethyl-1,2-Bnzanthracene und 20-Methylcholanthren. Tetrahedron 22, 2599–2608 (1966).CrossRefGoogle Scholar
  709. Wilk, M., Girke, W.: Radical cations of alternant hydrocarbons, amines, and azo dyes and their reactions with nucleo bases. In: Physico-chemical mechanisms of carcinogenesis. The Jerusalem Symposia on Quantum Chemistry and Biochemistry, ed. Bergmann, E.D., and Pullman, B., vol. I, p. 91–105. Jerusalem: Israel Academy of Science and Humanities 1969.Google Scholar
  710. Wilk, M., Gierke, W.: Reactions between benzo(a)pyrene and nucleobases by one electron oxidation. J. nat. Cancer Inst. 49, 1585–1597 (1972).PubMedGoogle Scholar
  711. Williams, D. J., Rabin, B. R.: The effects of aflatoxin and steroid hormones on polysome binding to microsomal membranes as measured by the activity of an enzyme catalysing disulphide interchange. FEBS Letters 4, 103–107 (1969).PubMedCrossRefGoogle Scholar
  712. Witschi, H., Epstein, S.M., Farber, E.: Influence of liver regeneration on the loss of fluorenylacet- amide derivative bound to liver DNA. Cancer Res. 31, 270–273 (1971).PubMedGoogle Scholar
  713. Wittkop, J.A., Prough, R.A., Reed, D.J.: Oxidative demethylation of N-methylhydrazines by rat liver microsomes. Arch. Biochem. Biophys. 134, 308–315 (1969).PubMedCrossRefGoogle Scholar
  714. Wogan, G.N.: Experimental toxicity and carcinogenicity of the aflatoxins, p. 163–173. In: G.N. WOGAN (ed.), Mycotoxins in foodstuffs. Cambridge Mass.: M.I.T. Press 1965.Google Scholar
  715. Wogan, G.N.: Chemical nature and biological effects of the aflatoxins. Bact. Rev. 30, 460–470 (1966).PubMedGoogle Scholar
  716. Wogan, G. N.: Metabolism and biochemical effects of aflatoxins. In: L. A. Goldblatt (ed.), Aflatoxin Scientific background control, and implications, p. 151–186. New York: Academic Press, Inc. 1969.Google Scholar
  717. Wogan, G.N., Edwards, G.S., Newberne, P.M.: Structure-activity relationships in toxicity and carcinogenicity of aflatoxins and analogs. Cancer Res. 31, 1936–1942 (1971).PubMedGoogle Scholar
  718. Wogan, G.N., Edwards, G.S., Shank, R.C.: Excretion and tissue distribution of radioactivity from aflatoxin Br14C in rats. Cancer Res. 27, 1729–1736 (1967).PubMedGoogle Scholar
  719. Wogan, G.N., Newberne, P.M.: Dose-response characteristics of aflatoxin carcinogenesis in the rat. Cancer Res. 27, 2370–2376 (1967).PubMedGoogle Scholar
  720. Wogan, G.N., Pong, R. S.: Aflatoxins. Ann. N. Y. Acad. Sci. 174, 623–635 (1970).CrossRefGoogle Scholar
  721. Wunderlich, V., Tetzlaff, I., Graffi, A.: Studies on nitrosodimethylamine: preferential methylation of mitochondrial DNA in rats and hamsters. Chem.-Biol. Interactions. 4, 81–89 (1971/72).Google Scholar
  722. Yagi, H., Jerina, D.M., Kasperek, G.J., Bruice, T.C.: A novel mechanism for the NIH shift. Proc. nat. Acad. Sci. (Wash.) 69, 1985–1986 (1972).CrossRefGoogle Scholar
  723. Yamamoto, N., Fukuda, S., Takebe, H.: Effect of a potent carcinogen, 4-nitroquinoline 1-oxide, and its reduced form, 4-hydroxyaminoquinoline 1-oxide, on bacterial and bacteriophage genomes. Cancer Res. 30, 2532–2537 (1970).PubMedGoogle Scholar
  724. Yuspa, S.H., Eaton, S. DEL A., Morgan, D.L., Bates, R.R.: The binding of 7,12-dimethylbenz(a)- anthracene to replicating and non-replicating DNA in cell culture. Chem.-Biol. Interactions 1,223–233 (1969/70).Google Scholar
  725. Zedeck, M.S., Sternberg, S.S., Poynter, R.W., Mcgowan, J.: Biochemical and pathological effects of methylazoxymethanol acetate, a potent carcinogen. Cancer Res. 30, 801–812 (1970).PubMedGoogle Scholar
  726. Zeiger, R.S., Salomon, R., Kinoshita, N., Peacock, A.C.: The binding of 9,10-dimethyl-l,2- benzanthracene to mouse epidermal satellite DNA in vivo. Cancer Res. 32, 643–647 (1972).PubMedGoogle Scholar
  727. Zeller, W.J., Ivankovic, S.: Steigerung der toxischen Wirkung von Älkylnitrosoharnstoff durch Schwermetalle. Naturwissenschaften 59, 82 (1972).PubMedCrossRefGoogle Scholar
  728. Zieve, F.J., Gutmann, H.R.: Reactivities of the carcinogens N-hydroxy-2-fluorenylacetamide and N-hydroxy-3-fluorenylacetamide with tissue nucleophiles. Cancer Res. 31, 471–476 (1971).PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1975

Authors and Affiliations

  • P. N. Magee
  • A. E. Pegg
  • P. F. Swann

There are no affiliations available

Personalised recommendations